<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Antibiotics for asymptomatic bacteriuria in pregnancy - Smaill, FM - 2019 | Cochrane Library</title> <meta content="Antibiotics for asymptomatic bacteriuria in pregnancy - Smaill, FM - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000490.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Antibiotics for asymptomatic bacteriuria in pregnancy - Smaill, FM - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000490.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD000490.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Antibiotics for asymptomatic bacteriuria in pregnancy" name="citation_title"/> <meta content="Fiona M Smaill" name="citation_author"/> <meta content="McMaster University" name="citation_author_institution"/> <meta content="smaill@mcmaster.ca" name="citation_author_email"/> <meta content="Juan C Vazquez" name="citation_author"/> <meta content="Instituto Nacional de Endocrinologia (INEN)" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD000490.pub4" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/11/25" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000490.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000490.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000490.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti‐Bacterial Agents [*therapeutic use]; Asymptomatic Infections; Bacteriuria [complications, *drug therapy]; Infant, Low Birth Weight; Pregnancy Complications, Infectious [*drug therapy]; Pregnancy Outcome; Premature Birth [prevention &amp; control]; Pyelonephritis [prevention &amp; control]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000490.pub4&amp;doi=10.1002/14651858.CD000490.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="eLIOL3Be";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD000490\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD000490\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000490\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000490\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANT","ru","th","ms","ja","fa","fr","ko","zh_HANS","de"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD000490.pub4",title:"Antibiotics for asymptomatic bacteriuria in pregnancy",firstPublishedDate:"Nov 25, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=eLIOL3Be&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000490.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000490.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD000490.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD000490.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000490.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD000490.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD000490.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD000490.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD000490.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD000490.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>34655 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD000490.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/full#CD000490-abs-0006"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/full#CD000490-sec-0118"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/full#CD000490-sec-0050"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/full#CD000490-sec-0051"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/full#CD000490-sec-0056"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/full#CD000490-sec-0057"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/full#CD000490-sec-0092"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/full#CD000490-sec-0112"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/appendices#CD000490-sec-0130"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/table_n/CD000490StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/table_n/CD000490StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Antibiotics for asymptomatic bacteriuria in pregnancy</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/information#CD000490-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Fiona M Smaill</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000490.pub4/information#CD000490-cr-0003">Juan C Vazquez</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/information/en#CD000490-sec-0140">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 25 November 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD000490.pub4">https://doi.org/10.1002/14651858.CD000490.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD000490-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000490-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD000490-abs-0019">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD000490-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000490-abs-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000490-abs-0004">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD000490-abs-0015">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD000490-abs-0002">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD000490-abs-0017">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD000490-abs-0001" lang="en"> <section id="CD000490-sec-0001"> <h3 class="title" id="CD000490-sec-0001">Background</h3> <p>Asymptomatic bacteriuria is a bacterial infection of the urine without any of the typical symptoms that are associated with a urinary infection, and occurs in 2% to 15% of pregnancies. If left untreated, up to 30% of mothers will develop acute pyelonephritis. Asymptomatic bacteriuria has been associated with low birthweight and preterm birth. This is an update of a review last published in 2015. </p> </section> <section id="CD000490-sec-0002"> <h3 class="title" id="CD000490-sec-0002">Objectives</h3> <p>To assess the effect of antibiotic treatment for asymptomatic bacteriuria on the development of pyelonephritis and the risk of low birthweight and preterm birth. </p> </section> <section id="CD000490-sec-0003"> <h3 class="title" id="CD000490-sec-0003">Search methods</h3> <p>For this update, we searched the Cochrane Pregnancy and Childbirth’s Trials Register, <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a>, the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) on 4 November 2018, and reference lists of retrieved studies. </p> </section> <section id="CD000490-sec-0004"> <h3 class="title" id="CD000490-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCT) comparing antibiotic treatment with placebo or no treatment in pregnant women with asymptomatic bacteriuria found on antenatal screening. Trials using a cluster‐RCT design and quasi‐RCTs were eligible for inclusion, as were trials published in abstract or letter form, but cross‐over studies were not. </p> </section> <section id="CD000490-sec-0005"> <h3 class="title" id="CD000490-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed trials for inclusion and risk of bias, extracted data, and checked for accuracy. We assessed the quality of the evidence using the GRADE approach. </p> </section> <section id="CD000490-sec-0006"> <h3 class="title" id="CD000490-sec-0006">Main results</h3> <p>We included 15 studies, involving over 2000 women. Antibiotic treatment compared with placebo or no treatment may reduce the incidence of pyelonephritis (average risk ratio (RR) 0.24, 95% confidence interval (CI) 0.13 to 0.41; 12 studies, 2017 women; low‐certainty evidence). Antibiotic treatment may be associated with a reduction in the incidence of preterm birth (RR 0.34, 95% CI 0.13 to 0.88; 3 studies, 327 women; low‐certainty evidence), and low birthweight babies (average RR 0.64, 95% CI 0.45 to 0.93; 6 studies, 1437 babies; low‐certainty evidence). There may be a reduction in persistent bacteriuria at the time of delivery (average RR 0.30, 95% CI 0.18 to 0.53; 4 studies; 596 women), but the results were inconclusive for serious adverse neonatal outcomes (average RR 0.64, 95% CI 0.23 to 1.79, 3 studies; 549 babies). There were very limited data on which to estimate the effect of antibiotics on other infant outcomes, and maternal adverse effects were rarely described. </p> <p>Overall, we judged only one trial at low risk of bias across all domains; the other 14 studies were assessed as high or unclear risk of bias. Many studies lacked an adequate description of methods, and we could only judge the risk of bias as unclear, but in most studies, we assessed at least one domain at high risk of bias. We assessed the quality of the evidence for the three primary outcomes with GRADE software, and found low‐certainty evidence for pyelonephritis, preterm birth, and birthweight less than 2500 g. </p> </section> <section id="CD000490-sec-0007"> <h3 class="title" id="CD000490-sec-0007">Authors' conclusions</h3> <p>Antibiotic treatment may be effective in reducing the risk of pyelonephritis in pregnancy, but our confidence in the effect estimate is limited given the low certainty of the evidence. There may be a reduction in preterm birth and low birthweight with antibiotic treatment, consistent with theories about the role of infection in adverse pregnancy outcomes, but again, the confidence in the effect is limited given the low certainty of the evidence. </p> <p>Research implications identified in this review include the need for an up‐to‐date cost‐effectiveness evaluation of diagnostic algorithms, and more evidence to learn whether there is a low‐risk group of women who are unlikely to benefit from treatment of asymptomatic bacteriuria. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD000490-abs-0006" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000490-abs-0006">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD000490-abs-0020">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD000490-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000490-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000490-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD000490-abs-0011">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD000490-abs-0016">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD000490-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD000490-abs-0008">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD000490-abs-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD000490-abs-0018">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD000490-abs-0007">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD000490-abs-0006" lang="en"> <h3>Antibiotics for bacterial infection in the urine in pregnancy when there are no symptoms</h3> <p><b>What is the issue?</b> </p> <p>Can giving antibiotics to pregnant women who have a urinary infection but no symptoms improve the outcomes for women and their babies? </p> <p><b>Why is this important?</b> </p> <p>A bacterial infection of the urine without any of the typical symptoms that are associated with a urinary infection (asymptomatic bacteriuria) occurs in a number (2% to 15%) of pregnancies. Because of the changes happening in their body, pregnant women are more likely to develop a kidney infection (pyelonephritis) if they have a urinary infection. The infection may also contribute to a baby who is born preterm (before 37 weeks), or at a low birthweight (weighs less than 2500 g (5.5 pounds)). </p> <p><b>What evidence did we find?</b> </p> <p>We found 15 randomised controlled studies involving over 2000 pregnant women with urinary infections, but no symptoms. Antibiotics may be effective in reducing the incidence of kidney infection in the mother (12 studies, 2017 women) and clearing the infection from the urine (four studies, 596 women). They may also reduce the incidence of preterm births (three studies, 327 women) and low birthweight babies (six studies, 1437 babies). None of the studies adequately assessed any adverse effects of antibiotic treatment for the mother or her baby, and often the way the study was done was not well described. </p> <p>We assessed the three main outcomes with the GRADE approach, and found low‐certainty evidence that antibiotic treatment may prevent pyelonephritis, preterm birth, and birthweight less than 2500 g. </p> <p><b>What does this mean?</b> </p> <p>Antibiotic treatment may reduce the risk of kidney infections in pregnant women who have a urine infection but show no symptoms of infection. Antibiotics may also reduce the chance a baby will be born too early or have a low birthweight. However, because of the low certainty of the evidence, it is difficult to draw conclusions; more research is needed. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD000490-sec-0118" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD000490-sec-0118"></div> <h3 class="title" id="CD000490-sec-0119">Implications for practice</h3> <section id="CD000490-sec-0119"> <p>Antibiotic treatment of asymptomatic bacteriuria may be indicated to reduce the risk of pyelonephritis in pregnancy, but the evidence is of low certainty. Both short course therapy and continuous treatment may reduce the incidence of pyelomephritis, but the evidence is of low certainty. </p> <p>The optimal time to perform the urine culture is unknown; in these studies, the urine culture was performed at the first prenatal visit, but a single culture before 20 weeks may miss more than half of women with asymptomatic bacteriuria (<a href="./references#CD000490-bbs2-0059" title="McIsaacW , CarrollJC , BiringerA , BernsteinP , LyonsE , LowDE , et al. Screening for asymptomatic bacteriuria in pregnancy. Journal of Obstetrics and Gynaecology Canada: JOGC2005;27(1):20‐4. ">McIsaac 2005</a>). </p> <p>In the studies included in this review, insufficient data were presented to determine the effectiveness of treatment to prevent recurrent bacteriuria; the studies did not specifically evaluate the effectiveness of a strategy of repeating a culture following treatment, and re‐treating as necessary. </p> </section> <h3 class="title" id="CD000490-sec-0120">Implications for research</h3> <section id="CD000490-sec-0120"> <p>This review has identified several implications for research.</p> <section id="CD000490-sec-0121"> <h5 class="title">Incorporating risk factors for pyelonephritis in a screening algorithm</h5> <p>In an era when routine prenatal screening for asymptomatic bacteriuria was standard, women with pyelonephritis were more likely to be black or Hispanic, young, less educated, nulliparous, initiate prenatal care late, and smoke during pregnancy (<a href="./references#CD000490-bbs2-0094" title="WingDA , FassettMJ , GetahunD . Acute pyelonephritis in pregnancy: an 18 year retrospective analysis. American Journal of Obstetrics and Gynecology2014;210(3):219. ">Wing 2014</a>). However, while some of these factors and other risk factors that are associated with asymptomatic bacteriuria may be amenable to interventions, or used to identify women at greater risk of an adverse outcome, there has been no evaluation of a screening algorithm that incorporates risk factors. </p> </section> <section id="CD000490-sec-0122"> <h5 class="title">Understanding the pathogenesis of infection</h5> <p>A better understanding of the basic mechanisms by which treatment of asymptomatic bacteriuria could prevent low birthweight is required. Any study of the relationship between other infections and adverse outcomes of pregnancy needs to control for asymptomatic bacteriuria and its treatment, but it is unlikely that the particular contribution of asymptomatic bacteriuria to preterm birth and low birthweight will ever be conclusively determined. </p> </section> <section id="CD000490-sec-0123"> <h5 class="title">The significance of lower colony counts and different urinary pathogens</h5> <p>The studies included in this review generally used a urine colony count of more than 100,000 bacteria/mL to identify participants. Although lower colony counts have been shown to be associated with active infection in other populations, their significance in pregnancy has not been established (<a href="./references#CD000490-bbs2-0079" title="StammWE , CountsGW , RunningKR , FihnS , TurckM , HolmesKK . Diagnosis of coliform infection in acutely dysuric women. New England Journal of Medicine1982;307:463‐8. ">Stamm 1982</a>). Treatment of asymptomatic pregnant women with lower colony counts is not currently recommended, but further study of appropriate strategies to manage these women is warranted, and there is an ongoing trial studying this question (<a href="./references#CD000490-bbs2-0022" title="NCT03275623 . Management of sub‐clinical bacteriuria in pregnancy: a feasibility trial. clinicaltrials.gov/ct2/show/NCT03275623 (first received 7 September 2017). [NCT03275623] ">NCT03275623</a>). <i>Staphylococcus saprophyticus</i> is a recognised cause of symptomatic infection in non‐pregnant women; however, the importance of this organism in asymptomatic pregnant women has not been established. While <i>E. coli</i> remains the predominant organism in most studies, the increasing prevalence of <i>Proteus mirabilis</i> and other Enterobacteriaceae<i>,</i> along with other <i>Staphylococcus</i> spp<i>.,</i> suggests different variables may be influencing the epidemiology of bacteriuria in developing countries (<a href="./references#CD000490-bbs2-0065" title="NicolleLE . Asymptomatic bacteriuria. Current Opinion in Infectious Diseases2014;27(1):90‐6. ">Nicolle 2014</a>). </p> <p>Studies now show that the urinary tract is not sterile; the role of the maternal urinary microbiome and organisms not detected by traditional culture methods in the outcomes of pregnancy is an interesting area of new research (<a href="./references#CD000490-bbs2-0054" title="KalinderiK , DelkosD , KalinderisM , AthanasiadidA , KalogiannidisI . Urinary tract infection during pregnancy: current concepts on a common multifaceted problem. Journal of Obstetrics and Gynaecology2018;38(4):448‐53. ">Kalinderi 2018</a>). </p> </section> <section id="CD000490-sec-0124"> <h5 class="title">Urine screening tests: methods, timing and frequency</h5> <p>Quantitative urine culture of a midstream or clean‐catch urine is the gold standard for detecting asymptomatic bacteriuria in pregnancy, but this test is expensive, and may not always be available in all clinical settings. Although rapid urine screening tests, for example, urine microscopy and urine dipstick, have not been shown to perform satisfactorily in this population, their use may be cost‐beneficial (<a href="./references#CD000490-bbs2-0075" title="RouseDJ , AndrewsWW , GoldenbergRL , OwenJ . Screening and treatment of asymptomatic bacteriuria of pregnancy to prevent pyelonephritis: a cost‐effectiveness and cost‐beneficial analysis. Obstetrics and Gynecology1995;86:119‐23. ">Rouse 1995</a>). Any new urine screening test that is developed needs to be evaluated in the context of screening for asymptomatic bacteriuria of pregnancy. </p> <p>None of these studies adequately addressed the most appropriate time to perform the initial screening culture, how often to repeat a negative culture, or how best to monitor women initially treated for asymptomatic bacteriuria. There is a need to define the appropriate frequency of follow‐up cultures and re‐treatment strategies. </p> </section> <section id="CD000490-sec-0125"> <h5 class="title">Adherence to guidelines</h5> <p>Despite almost uniform national guidelines, there is little evidence of adherence to screening recommendations. In Australia, poor adherence with screening for asymptomatic bacteriuria in indigenous communities has been proposed as one explanation for worse pregnancy outcomes in this population; a structural problem related to provision of care in remote communities was identified as the cause (<a href="./references#CD000490-bbs2-0035" title="BookallilM , ChalmersE , AndrewB . Challenges in preventing pyelonephritis in pregnant women in Indigenous communities. Rural and Remote Health2005;5(3):395. ">Bookallil 2005</a>). Screening rates from 1% to 96% were reported in a pilot survey of quality indicators of antenatal care in the UK (<a href="./references#CD000490-bbs2-0085" title="VauseS , MareshM . Indicators of quality of antenatal care: a pilot study. British Journal of Obstetrics and Gynaecology1999;106:197‐205. ">Vause 1999</a>). There is an opportunity to evaluate screening for asymptomatic bacteriuria as a measure of quality of care, and gain a better understanding of the implementation of screening policies for asymptomatic bacteriuria in low‐income countries. </p> </section> <section id="CD000490-sec-0126"> <h5 class="title">Cost‐effectiveness</h5> <p>While there are no new data to indicate that women should not be screened for asymptomatic bacteriuria, it is difficult to estimate accurately the cost‐effectiveness of screening without up‐to‐date information on the prevalence of asymptomatic bacteriuria, and a more accurate estimate of the reduction in pyelonephritis, low birthweight, and preterm births with treatment. A Health Technology Assessment report from the UK on screening to prevent preterm birth estimated that antibiotic treatment for all women without any testing was the most cost‐effective option for preventing birth before 37 weeks; however, they did not take into account the potential side effects of antibiotics or issues, such as resistance, and the conclusions were based on low‐quality evidence associating treatment with a reduction in preterm births (<a href="./references#CD000490-bbs2-0051" title="HonestH , ForbesCA , DuréeKH , NormanG , DuffySB , TsourapasA , et al. Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technology Assessment2009;13(43):1‐627. [DOI: 10.3310/hta13430] ">Honest 2009</a>). There needs to be prospective evaluation of cost‐effective diagnostic algorithms, that include risk factors and up‐to‐date outcomes, in different populations. </p> </section> <section id="CD000490-sec-0127"> <h5 class="title">Research in low‐risk populations</h5> <p>Despite the demonstrated association between antibiotic treatment and the prevention of pyelonephritis, there is an opportunity for research to provide better quality data to inform the management of asymptomatic bacteriuria. <a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a> performed a carefully designed randomised, placebo‐controlled trial in a low risk group of pregnant women, and although they enrolled 248 women with asymptomatic bacteriuria in their cohort, only 95 (33%) were enrolled in the randomised controlled trial of treatment, limiting the generalisability of the results, and compromising the power of the study (<a href="./references#CD000490-bbs2-0066" title="NicolleLE . Management of asymptomatic bacteriuria in pregnant women. Lancet Infectious Diseases2015;15:1252‐4. ">Nicolle 2015</a>). Further, well‐designed clinical trials could provide useful information on alternative management strategies and adverse events of treatment. The majority (66%) of women with asymptomatic bacteriuria in <a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a> declined to participate in the randomised trial because they did not want to receive antibiotics for an asymptomatic condition; further research should explore these low‐risk women's values and preferences regarding treatment of asymptomatic bacteriuria. Preventing inappropriate and unnecessary antibiotic use has become an important community‐wide goal, giving researchers the impetus to produce high‐quality evidence that could identify women with asymptomatic bacteriuria in whom antibiotic treatment may not be necessary. </p> </section> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD000490-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD000490-sec-0050"></div> <div class="table" id="CD000490-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antibiotics compared to no treatment for asymptomatic bacteriuria in pregnancy</span></div> <tbody> <tr class="table-header separated"> <td align="left" class="table-header" colspan="7" rowspan="1" valign="top"> <p><b>Antibiotics compared to no treatment for asymptomatic bacteriuria in pregnancy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> pregnant women with asymptomatic bacteriuria </p> <p><b>Setting:</b> hospital‐based clinics in North America, UK and Ireland, Australia; hospital and community midwifery practices in the Netherlands </p> <p><b>Intervention:</b> antibiotics </p> <p><b>Comparison:</b> no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with antibiotics</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Development of pyelonephritis</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.24<br/> (0.13 to 0.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2017<br/> (12 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>199 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>48 per 1000<br/> (26 to 82) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Preterm birth &lt; 37 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.34<br/> (0.13 to 0.88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>327<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>174 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>59 per 1000<br/> (23 to 153) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Birthweight &lt; 2500 g</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.64<br/> (0.45 to 0.93) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1437<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>e,f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>136 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>87 per 1000<br/> (61 to 126) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded 1 level for serious limitations in study design: most of the trials contributing outcome data either had important design limitations related to lack of allocation concealment and lack of blinding, or there were insufficient details provided in the report to assess risk of bias. Many of the studies were performed in the 1960s and 1970s, prior to more rigorous study designs and reporting standards.<br/> <sup>b</sup>We downgraded 1 level for serious limitations in inconsistency: the rate of pyelonephritis in the control groups ranged from 2.2% to 36%; there was significant heterogeneity, which was not explained by the duration of treatment (I² = 60%).<br/> <sup>c</sup>We downgraded 1 level for serious limitations in study design: only one trial was judged at low risk of bias across all domains; for the other two, the risk of bias was either unclear because details were not provided, or judged high risk.<br/> <sup>d</sup>We downgraded 1 level for serious limitations in indirectness: the rate of preterm birth in the control group ranged from 4.4% to 37.5%. There have been substantial changes in obstetric practices over the four decades from the earliest to the latest study. In one study, only women with group B streptococcus bacteriuria were enrolled, and treatment was with penicillin.<br/> <sup>e</sup>We downgraded 1 level for serious limitations in study design: all of the trials contributing outcome data either had important design limitations related to lack of allocation concealment and lack of blinding, or there were insufficient details provided in the report to assess risk of bias. The studies contributing data to this outcome were performed in the 1960s and 1970s, prior to more rigorous study designs and reporting standards.<br/> <sup>f</sup>We downgraded 1 level for serious limitations in indirectness: 5 of the 6 studies included in this outcome continued antibiotic treatment for 6 weeks (1 study), or until term (4 studies). In one study, women received a single dose of antibiotics, and in no study did women receive what is now considered a standard course of antibiotics for 3 to 7 days. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD000490-sec-0051" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD000490-sec-0051"></div> <section id="CD000490-sec-0052"> <h3 class="title" id="CD000490-sec-0052">Description of the condition</h3> <p>Asymptomatic bacteriuria, generally defined as true bacteriuria in the absence of specific symptoms of acute urinary tract infection, is a common finding, and occurs in 2% to 15% of all pregnancies (<a href="./references#CD000490-bbs2-0052" title="IpeDS , SundasL , BenjaminWH , MooreKH , UlettGC . Asymptomatic bacteriuria: prevalence rates of causal microorganisms, etiology of infection in different patient populations, and recent advances in molecular detection. FEMS Microbiology Letters2013;346:1‐10. ">Ipe 2013</a>). </p> <p>While rates from recent observational studies fall within this range (<a href="./references#CD000490-bbs2-0023" title="Abdel‐AzizEM , Barnett‐vanesA , DabourMF , ChengF . Prevalence of undiagnosed asymptomatic bacteriuria and associated risk factors during pregnancy: a cross‐sectional study at two tertiary centres in Cairo, Egypt. BMJ Open2017;7(3):e013198. ">Abdel‐Aziz 2017</a>; <a href="./references#CD000490-bbs2-0033" title="BandyopadhyayS , ThakurJS , RayP , KumarR . High prevalence of bacteriuria in pregnancy and its screening methods in north India. Journal of the Indian Medical Association2005;103(5):259‐62, 266. ">Bandyopadhyay 2005</a>; <a href="./references#CD000490-bbs2-0036" title="CelenS , OrusAS , KaravalcinR , SayganS , UnluS , PolatB , et al. Asymptomatic bacteriuria and antibacterial susceptibility patterns in an obstetric population. ISRN Obstetrics and Gynecology2011;2011:721872. [DOI: 10.5402/2011/721872] ">Celen 2011</a>; <a href="./references#CD000490-bbs2-0041" title="FatimaN , IshratS . Frequency and risk factors of asymptomatic bacteriuria during pregnancy. Journal of the College of Physicians and Surgeons Pakistan2006;16(4):273‐5. ">Fatima 2006</a>; <a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>; <a href="./references#CD000490-bbs2-0059" title="McIsaacW , CarrollJC , BiringerA , BernsteinP , LyonsE , LowDE , et al. Screening for asymptomatic bacteriuria in pregnancy. Journal of Obstetrics and Gynaecology Canada: JOGC2005;27(1):20‐4. ">McIsaac 2005</a>; <a href="./references#CD000490-bbs2-0060" title="McNairRD , MacDonaldSR , DooleySL , PetersonLR . Evaluation of the centrifuged and Gram‐stained smear, urinalysis, and reagent strip testing to detect asymptomatic bacteriuria in obstetric patients. American Journal of Obstetrics and Gynecology2000;182(5):1076‐9. [MEDLINE: 10819832] ">McNair 2000</a>; <a href="./references#CD000490-bbs2-0018" title="MohammadM , MahdyZA , OmarJ , MaanN , JamilMA . Laboratory aspects of asymptomatic bacteriuria in pregnancy. Southeast Asian Journal of Tropical Medicine and Public Health2002;33(3):575‐80. ">Mohammad 2002</a>; <a href="./references#CD000490-bbs2-0068" title="OlamijuloJA , AdewaleCO , OlaleyeO . Asymptomatic bacteriuria among antenatal women in Lagos. Journal of Obstetrics and Gynaecology2016;36(6):722‐5. ">Olamijulo 2016</a>; <a href="./references#CD000490-bbs2-0083" title="TugrulS , OralO , KumruP , KoseD , AlkanA , YildirimG . Evaluation and importance of asymptomatic bacteriuria in pregnancy. Clinical and Experimental Obstetrics and Gynecology2005;32(4):237‐40. ">Tugrul 2005</a>), rates of over 20% are reported in studies from some low‐income countries (<a href="./references#CD000490-bbs2-0024" title="AjayiAB , NwabuisiC , AboyejiAP , AjayiNS , FowotadeA , FakeyeOO . Asymptomatic bacteriuria in antenatal patients in Ilorin, Nigeria. Oman Medical Journal2012;27(1):31‐5. ">Ajayi 2012</a>; <a href="./references#CD000490-bbs2-0071" title="RizviM , KhanF , ShuklaI , MalikA , ShaheenMA . Rising prevalence of antimicrobial resistance in urinary tract infections during pregnancy: necessity for exploring newer treatment options. Journal of Laboratory Physicians2011;3(2):98‐103. ">Rizvi 2011</a>; <a href="./references#CD000490-bbs2-0082" title="TadessE , TeshomeM , MeridY , KibretB , ShimelisT . Asymptomatic urinary tract infection among pregnant women attending the antenatal clinic of Hawassa Referral Hospital, Southern Ethiopia. BMC Research Notes2014;17(7):155. ">Tadesse 2014</a>). The prevalence of asymptomatic bacteriuria was reported to be as high as 86.6% in a population from Nigeria that included <i>Staphylococcus aureus</i>, a possible contaminant, as a uropathogen (<a href="./references#CD000490-bbs2-0025" title="AkereleJ , AbhulimenP , OkonofuaF . Prevalance of asymptomatic bacteriuria among pregnant women in Benin City, Nigeria. Journal of Obstetrics and Gynaecology2001;21(2):141‐4. ">Akerele 2001</a>). Rates were reported to be higher in HIV positive women in Nigeria (<a href="./references#CD000490-bbs2-0031" title="AwoludeOA , AdesinaOA , OladokunA , MutiuWB , AdewoleIF . Asymptomatic bacteriuria among HIV positive pregnant women. Virulence2010;1(3):130‐3. ">Awolude 2010</a>; <a href="./references#CD000490-bbs2-0039" title="EzechiOC , Gab‐OkaforCV , OladeleDA , KalejaiyeOO , OkeBO , EkamaSO , et al. Prevalence and risk factors of asymptomatic bacteriuria among pregnant Nigerians infected with HIV. Journal of Maternal‐fetal &amp; Neonatal Medicine2014;26(4):402‐6. ">Ezechi 2013</a>), but not in a study from South Africa (<a href="./references#CD000490-bbs2-0090" title="WidmerTA , TheronG , GroveD . Prevalence and risk factors of asymptomatic bacteriuria among HIV positive women. South African Journal of Epidemiology and Infection2010;25(1):28‐32. ">Widmer 2010</a>). In a large retrospective study, the strongest predictor of bacteriuria was an antepartum urinary tract infection (<a href="./references#CD000490-bbs2-0069" title="PastoreLM , SavitzDA , ThorpJM . Predictors of urinary tract infection at the first prenatal visit. Epidemiology1999;10(3):282‐7. ">Pastore 1999</a>). A study from an electronics factory in China found an association between urinary tract infections in pregnancy and frequency of voiding; voiding three or more times a shift was protective (<a href="./references#CD000490-bbs2-0081" title="SuSB , WangJN , LuCW , WangHY , GuoHR . Prevalence of urinary tract infections and associated factors among pregnant workers in the electronics industry. International Urogynecology Journal and Pelvic Floor Dysfunction2009;20(8):939‐45. ">Su 2009</a>). In a study from Iran, there was an association between infection, frequency of sexual intercourse, and genital hygiene practices (<a href="./references#CD000490-bbs2-0027" title="AmiriFN , RooshanMH , AhmadyMH , SoliamaniMJ . Hygiene practices and sexual activity associated with urinary tract infection in pregnant women. East Mediterrean Health Journal2009;15(1):104‐10. ">Amiri 2009</a>). The prevalence of infection is related to socioeconomic status (<a href="./references#CD000490-bbs2-0046" title="HaiderG , ZehraN , MunirAA , HaiderA . Risk factors of urinary tract infection in pregnancy. Journal of Pakistan Medical Association2010;60(3):213‐6. ">Haider 2010</a>; <a href="./references#CD000490-bbs2-0084" title="TurckM , GoffBS , PetersdorfRG . Bacteriuria in pregnancy; relationship to socioeconomic factors. New England Journal of Medicine1962;266:857‐60. ">Turck 1962</a>; <a href="./references#CD000490-bbs2-0088" title="WhalleyP . Bacteriuria of pregnancy. American Journal of Obstetrics and Gynecology1967;97:723‐38. ">Whalley 1967</a>), although this may not always apply (<a href="./references#CD000490-bbs2-0030" title="AwolekeJO , AdanikinAI , AjayiDD , AyosanmiOS . Predictors of asymptomatic bacteriuria among pregnant women in a low‐resource setting. Journal of Obstetrics and Gynaecology2015;35(1):25‐9. ">Awoleke 2015</a>; <a href="./references#CD000490-bbs2-0057" title="KovavisarachE , VichaipruckM , KanjarahareutaiS . Risk factors related to asymptomatic bacteriuria in pregnant women. Journal of Medical Association of Thailand2009;92(5):606‐10. ">Kovavisarach 2009</a>). Other contributing factors, recognised as associated with an increased risk for bacteriuria, include diabetes and anatomical abnormalities of the urinary tract. </p> <p>The original criterion for diagnosing asymptomatic bacteriuria was a count of more than 100,000 bacteria/mL on two consecutive clean‐catch samples (<a href="./references#CD000490-bbs2-0055" title="KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little, Brown and Co, 1960:399‐412. ">Kass 1960a</a>). The detection of more than 100,000 bacterial/mL in a single voided midstream urine sample is accepted as an adequate and more practical alternative, although there is only an 80% probability the woman has true bacteriuria; this increases to 95% if two or more consecutive cultures are positive for the same organism (<a href="./references#CD000490-bbs2-0055" title="KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little, Brown and Co, 1960:399‐412. ">Kass 1960a</a>). Because the performance of rapid urine screening tests in pregnancy is poor, quantitative culture remains the gold standard for diagnosis (<a href="./references#CD000490-bbs2-0032" title="BachmanJW , HeiseRH , NaessensJM , TimmermanMG . A study of various tests to detect asymptomatic urinary tract infections in an obstetric population. JAMA1993;270:1971‐4. ">Bachman 1993</a>; <a href="./references#CD000490-bbs2-0042" title="Garingalo‐MolinaFD . Asymptomatic bacteriuria among pregnant women: overview of diagnostic approaches. Philippine Journal of Microbiology and Infectious Diseases2000;29:177‐86. ">Garingalo‐Molina 2000</a>; <a href="./references#CD000490-bbs2-0060" title="McNairRD , MacDonaldSR , DooleySL , PetersonLR . Evaluation of the centrifuged and Gram‐stained smear, urinalysis, and reagent strip testing to detect asymptomatic bacteriuria in obstetric patients. American Journal of Obstetrics and Gynecology2000;182(5):1076‐9. [MEDLINE: 10819832] ">McNair 2000</a>; <a href="./references#CD000490-bbs2-0063" title="MigniniL , CarroliG , AbalosE , WidmerM , AmigotS , NardinJM , et al. Accuracy of diagnostic tests to detect symptomatic bacteriuria during pregnancy. Obstetrics and Gynecology2009;113(2 (Pt 1)):346‐52. ">Mignini 2009</a>; <a href="./references#CD000490-bbs2-0072" title="RogozińskaE , ForminaS , ZamoraJ , MigniniL , KhanKS . Accuracy of onsite tests to detect asymptomatic bacteriuria in pregnancy: a systematic review and meta‐analysis. Obstetrics and Gynecology2016;128:495‐502. ">Rogozińska 2016</a>). </p> <p><i>Escherichia coli</i> is the most common pathogen associated with asymptomatic bacteriuria, representing up to 80% of isolates (<a href="./references#CD000490-bbs2-0052" title="IpeDS , SundasL , BenjaminWH , MooreKH , UlettGC . Asymptomatic bacteriuria: prevalence rates of causal microorganisms, etiology of infection in different patient populations, and recent advances in molecular detection. FEMS Microbiology Letters2013;346:1‐10. ">Ipe 2013</a>). Other organisms include other gram‐negative bacteria, e.g. <i>Klebsiella</i> spp., <i>Proteus mirabilis</i> , and group B streptococci. These bacteria colonise the vaginal introitus and periurethral area. Uropathogenic gram‐negative bacteria possess specific virulence factors that enhance both colonisation and invasion of the urinary tract, for example, the P‐fimbriae of certain strains of <i>E. coli</i> that allow for adherence to uroepithelial cells (<a href="./references#CD000490-bbs2-0037" title="EisensteinBI , JonesGW . The spectrum of infections and pathogenic mechanisms of Escherichia coli. Advances in Internal Medicine1988;33:231‐52. ">Eisenstein 1988</a>; <a href="./references#CD000490-bbs2-0080" title="StenqvistK , SandbergT , Lidin‐JansonG , OrskovF , OrskovL , Svanborg‐EdenC . Virulence factors of Escherichia coli in urinary isolates from pregnant women. Journal of Infectious Diseases1987;156(6):870‐7. ">Stenqvist 1987</a>). Some strains of <i>E. coli</i> isolated from pregnant women with asymptomatic bacteriuria have a similar virulence pattern to strains from women with symptomatic infections (<a href="./references#CD000490-bbs2-0058" title="LavigneJ‐P , Boutet‐DuboisA , LaouiniD , CombescureC , BouzigesN , MaresP , et al. Virulence potential of Escherichia coli strains causing asymptomatic bacteriuria during pregnancy. Journal of Clinical Microbiology2011;49(11):3950‐3. ">Lavigne 2011</a>), but this does not always hold true (<a href="./references#CD000490-bbs2-0080" title="StenqvistK , SandbergT , Lidin‐JansonG , OrskovF , OrskovL , Svanborg‐EdenC . Virulence factors of Escherichia coli in urinary isolates from pregnant women. Journal of Infectious Diseases1987;156(6):870‐7. ">Stenqvist 1987</a>). While <i>Staphylococcus saprophyticus</i> is recognised as a urinary pathogen, other species of <i>Staphylococci</i> , including <i>Staphylococcus aureus,</i> may reflect contamination rather than a true infection, and prevalence data where the number of <i>Staphylococcus</i> spp. is high, are difficult to interpret. Maternal urinary tract infection with group B streptococci is associated with vaginal colonisation with the organism, and antibiotic treatment during labour is recommended to prevent early onset neonatal group B streptococcal disease (<a href="./references#CD000490-bbs2-0026" title="AllenVM , YudinMH , BouchardC , BoucherM , CaddyS , CastilloE , et al. Management of group B streptococcal bacteriuria in pregnancy. Journal of Obstetrics and Gynaecology Canada: JOGC2012;34(5):482‐6. ">Allen 2012</a>). </p> <p>While asymptomatic bacteriuria in non‐pregnant women is generally benign, obstruction to the flow of urine in pregnancy leads to stasis, and increases the likelihood that pyelonephritis will complicate asymptomatic bacteriuria (<a href="./references#CD000490-bbs2-0065" title="NicolleLE . Asymptomatic bacteriuria. Current Opinion in Infectious Diseases2014;27(1):90‐6. ">Nicolle 2014</a>). Mechanical compression from the enlarging uterus is the principal cause of hydroureter and hydronephrosis, but smooth muscle relaxation induced by progesterone may also play a role (<a href="./references#CD000490-bbs2-0078" title="SobelJD , KayeD . Urinary tract infections. In: MandellGL , BennettJE , DolinR editor(s). Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 4th Edition. New York: Churchill Livingstone, 1995:662‐90. ">Sobel 1995</a>). Differences in urine pH and osmolality and pregnancy‐induced glycosuria and aminoaciduria may facilitate bacterial growth. If asymptomatic bacteriuria in pregnancy is untreated, it has generally been accepted that up to 20% to 30% of mothers will develop acute pyelonephritis (<a href="./references#CD000490-bbs2-0066" title="NicolleLE . Management of asymptomatic bacteriuria in pregnant women. Lancet Infectious Diseases2015;15:1252‐4. ">Nicolle 2015</a>). Current estimates are difficult to identify because there is almost universal implementation of screening and treatment, however, a recent study from a low‐risk population in the Netherlands, where screening never became standard, reported a rate of pyelonephritis of 2.4% (<a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>). Clinical signs of pyelonephritis include fever, chills, costovertebral tenderness, dysuria, and frequency. Nausea and vomiting are common, and if infection is associated with bacteraemia, women may present with high fever, shaking chills, and low blood pressure. Maternal complications include maternal respiratory insufficiency, septicaemia, renal dysfunction, and anaemia (<a href="./references#CD000490-bbs2-0050" title="HillJB , SheffieldJS , McIntireDD , WendelGD . Acute pyelonephritis in pregnancy. Obstetrics and Gynecology2005;105(1):18‐23. ">Hill 2005</a>; <a href="./references#CD000490-bbs2-0094" title="WingDA , FassettMJ , GetahunD . Acute pyelonephritis in pregnancy: an 18 year retrospective analysis. American Journal of Obstetrics and Gynecology2014;210(3):219. ">Wing 2014</a>). In the pre‐antibiotic era, acute pyelonephritis was associated with a 20% to 50% incidence of preterm birth. A prospective longitudinal study, in the era of routine screening, over a two‐year period from 2000 to 2001 in Texas, reported an incidence of acute pyelonephritis in pregnancy of 1.4% (<a href="./references#CD000490-bbs2-0050" title="HillJB , SheffieldJS , McIntireDD , WendelGD . Acute pyelonephritis in pregnancy. Obstetrics and Gynecology2005;105(1):18‐23. ">Hill 2005</a>). From an 18‐year retrospective review, in an era of routine screening and treatment for asymptomatic bacteriuria, the incidence of acute pyelonephritis in pregnancy was 0.5%, and pyelonephritis was associated with preterm birth (odds ratio (OR) 1.3, 95% confidence interval (CI) 1.2 to 1.5); women with pyelonephritis were more likely to be black or Hispanic, young, less educated, initiate prenatal care late, and smoke (<a href="./references#CD000490-bbs2-0094" title="WingDA , FassettMJ , GetahunD . Acute pyelonephritis in pregnancy: an 18 year retrospective analysis. American Journal of Obstetrics and Gynecology2014;210(3):219. ">Wing 2014</a>). An association between acute pyelonephritis and preterm birth was described in a retrospective study of 219,612 deliveries from Israel (OR 2.6, 95% CI 1.7 to 3.9; <a href="./references#CD000490-bbs2-0040" title="FarkashE , WeintraubAY , SergienkoR , WiznitzerA , ZlotnikA , SheinerE . Acute antepartum pyelonephritis in pregnancy: a critical analysis of risk factors and outcomes. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;162(1):24‐7. ">Farkash 2012</a>). </p> <p>An association between asymptomatic bacteriuria, low birthweight, and preterm birth has been described since the earliest studies of Kass (<a href="./references#CD000490-bbs2-0055" title="KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little, Brown and Co, 1960:399‐412. ">Kass 1960a</a>), but population‐based studies have produced conflicting results. A retrospective study from Israel, which controlled for confounders, showed an association between asymptomatic bacteriuria and preterm birth (OR 1.9, 95% CI 1.7 to 2.0; <a href="./references#CD000490-bbs2-0077" title="SheinerE , Mazor‐DreyE , LevyA . Asymptomatic bacteriuria during pregnancy. Journal of Maternal‐fetal &amp; Neonatal Medicine2009;22(5):423‐7. ">Sheiner 2009</a>); in contrast, findings from the Cardiff Birth Survey reported that asymptomatic bacteriuria, adjusted for demographic and social factors, was not associated with preterm birth (OR 1.2, 95% CI 0.9 to 1.5; <a href="./references#CD000490-bbs2-0061" title="MeisPJ , MichielutteR , PetersTJ , WellsHB , SandsRE , ColesEC , et al. Factors associated with preterm birth in Cardiff, Wales. I. Univariable and multivariable analysis. American Journal of Obstetrics and Gynecology1995;173(2):590‐6. ">Meis 1995</a>). However, when preterm deliveries were categorised into those medically indicated because of complications of pregnancy (e.g. antepartum haemorrhage, eclampsia, or renal disease) and spontaneous preterm births, there was a significant association between bacteriuria and medically‐indicated preterm deliveries (OR 2.03, 95% CI 1.5 to 2.8), but not for spontaneous preterm births (OR 1.07, 95% CI 0.78 to 1.46). The authors concluded that if asymptomatic bacteruria does not progress to pyelonephritis, it is not associated with preterm birth (<a href="./references#CD000490-bbs2-0062" title="MeisPJ , MichielutteR , PetersTJ , WellsHB , SandsRE , ColesEC , et al. Factors associated with preterm birth in Cardiff, Wales. II. Indicated and spontaneous preterm birth. American Journal of Obstetrics and Gynecology1995;173(2):597‐602. ">Meis 1995a</a>). </p> </section> <section id="CD000490-sec-0053"> <h3 class="title" id="CD000490-sec-0053">Description of the intervention</h3> <p>The goal of treatment for asymptomatic bacteriuria is to treat and clear the infection. The urinary bacterial isolate should be susceptible to the antibiotic chosen, the length of treatment should be adequate, adherence should be assured, and the drug should have favourable pharmacokinetic parameters. The treatment should be safe in pregnancy, for both the mother and developing fetus. Many antibiotics have been used to treat bacteriuria, including sulphonamides or sulphonamide‐containing combinations, penicillins, cephalosporins, fosfomycin, and nitrofurantoin. However, not all the antibiotics previously evaluated are currently available, e.g. certain sulphonamides and methenamine, or recommended during pregnancy, e.g. tetracycline. Increasing bacterial resistance of urinary pathogens can make it difficult to select an appropriate regimen, especially in under‐resourced settings, where facilities for urine culture and antimicrobial susceptibility testing are limited (<a href="./references#CD000490-bbs2-0029" title="AssefaA , AsratD , WoldeamanuelY , G/HiwotY , AbdellaA , MelesseT . Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at Tikur Anbessa Specialized Hospital Addis Ababa, Ethiopia. Ethiopian Medical Journal2008;46(3):227‐35. ">Assefa 2008</a>; <a href="./references#CD000490-bbs2-0038" title="EnayatK , FaribaF , BahramN . Asymptomatic bacteriuria among pregnant women referred to outpatient clinics in Sanandaj, Iran. International Brazilian Journal of Urology2008;34(6):699‐704. ">Enayat 2008</a>; <a href="./references#CD000490-bbs2-0048" title="Hernandez BlasF , Lopez CarmonaJM , Rodriguez MoctezumaJR , Peralta PedreroML , Rodriguez GulierrezRS , Ortiz AguirreAR . Asymptomatic bacteriuria frequency in pregnant women and uropathogen in vitro antimicrobial sensitivity. Ginecologia y Obstetricia de Mexico2007;75(6):325‐31. ">Hernandez Blas 2007</a>; <a href="./references#CD000490-bbs2-0071" title="RizviM , KhanF , ShuklaI , MalikA , ShaheenMA . Rising prevalence of antimicrobial resistance in urinary tract infections during pregnancy: necessity for exploring newer treatment options. Journal of Laboratory Physicians2011;3(2):98‐103. ">Rizvi 2011</a>; <a href="./references#CD000490-bbs2-0082" title="TadessE , TeshomeM , MeridY , KibretB , ShimelisT . Asymptomatic urinary tract infection among pregnant women attending the antenatal clinic of Hawassa Referral Hospital, Southern Ethiopia. BMC Research Notes2014;17(7):155. ">Tadesse 2014</a>). There is no evidence that non‐pharmacological interventions, e.g. cranberry juice, are effective (<a href="./references#CD000490-bbs2-0093" title="WingDA , RumneyPJ , PreslickaCW , ChungJH . Daily cranberry juice for the prevention of asymptomatic bacteriuria in pregnancy: a randomized, controlled pilot study. Journal of Urology2008;180(4):1367‐72. ">Wing 2008</a>), although no data exist to suggest the use of cranberry has any harmful effects on pregnancy (<a href="./references#CD000490-bbs2-0047" title="HeitmannK , NordengH , HolstL . Pregnancy outcome after use of cranberry in pregnancy ‐ the Norwegian Mother and Child cohort study. BMC Complementary and Alternative Medicine2013;13:345. ">Heitmann 2013</a>). </p> </section> <section id="CD000490-sec-0054"> <h3 class="title" id="CD000490-sec-0054">How the intervention might work</h3> <p>Urinary pathogens causing asymptomatic bacteriuria are similar to those causing pyelonephritis; antibiotic treatment and eradication of bacteriuria is expected to prevent ascending urinary tract infection and the development of clinical pyelonephritis. </p> <p>The relationship between asymptomatic bacteriuria, low birthweight, and preterm birth is controversial, since a biological mechanism for an association between preterm labor and asymptomatic bacteriuria has not been established. Microbial‐induced preterm labor is mediated by an inflammatory process (<a href="./references#CD000490-bbs2-0043" title="GoldbergRL , HauthJC , AndrewsWW . Mechanisms of disease: intrauterine infection and preterm delivery. New England Journal of Medicine2000;342(20):1500‐7. ">Goldenberg 2000</a>; <a href="./references#CD000490-bbs2-0074" title="RomeroA , DeySK , FisherSJ . Preterm labor: one syndrome, many causes. Science2014;345(6198):760‐5. ">Romero 2014</a>). Microorganisms and their products are sensed by pattern‐recognition receptors, such as toll‐like receptors (TLRs), which induce the production of chemokines, prostaglandins, and proteases, leading to the onset of labour. While this mechanism has been well defined for ascending intra‐amniotic infection, there has been no recent research to explore the mechanisms through which asymptomatic bacteriuria might exert adverse pregnancy outcomes. </p> </section> <section id="CD000490-sec-0055"> <h3 class="title" id="CD000490-sec-0055">Why it is important to do this review</h3> <p>Screening for, and treating asymptomatic bacteriuria in pregnancy, has become a standard of obstetric care. While most antenatal guidelines include routine screening for asymptomatic bacteriuria, questions have been raised about the quality of the evidence on which these guidelines are based, and the lack of data on the harms of screening (<a href="./references#CD000490-bbs2-0028" title="AngelescuK , Nussbaumer‐StreitB , SiebenW , ScheibierF , GartlehnerG . Benefits and harms of screening for and treatment of asymptomatic bacteriuria in pregnancy: a systematic review. BMC Pregnancy Childbirth2016;16(1):336. ">Angelescu 2016</a>; <a href="./references#CD000490-bbs2-0064" title="MooreA , DoullM , GradR , GroulxS , PottieK , TonelliM , et al. Recommendations on screening for asymptomatic bacteriuria in pregnancy. CMAJ2018;190(27):E823‐30. ">Moore 2018</a>). Using a decision analysis, screening for, and treating asymptomatic bacteriuria to prevent pyelonephritis, has been shown to be cost‐effective over a wide range of estimates, although the cost‐benefit is diminished if the rate of asymptomatic bacteriuria is less than 2% (<a href="./references#CD000490-bbs2-0075" title="RouseDJ , AndrewsWW , GoldenbergRL , OwenJ . Screening and treatment of asymptomatic bacteriuria of pregnancy to prevent pyelonephritis: a cost‐effectiveness and cost‐beneficial analysis. Obstetrics and Gynecology1995;86:119‐23. ">Rouse 1995</a>; <a href="./references#CD000490-bbs2-0087" title="WadlandWC , PlanteDA . Screening for asymptomatic bacteriuria in pregnancy. A decision and cost analysis. Journal of Family Practice1989;29:372‐6. ">Wadland 1989</a>). The low prevalence of infection in certain populations, the cost of different screening tests, and uncertainty about the benefits of treatment in decreasing adverse outcomes of pregnancy have been used to argue against screening and treatment as universal recommendations; preventing unnecessary antibiotic use has become an important aspect of programmes to decrease the development of antimicrobial resistance. A rigorous evaluation of studies of the effect of treatment of asymptomatic bacteriuria could provide clarity around these issues. This is an update of a review last published in 2015 (<a href="./references#CD000490-bbs2-0099" title="SmaillFM , VazquezJC . Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database of Systematic Reviews2015, Issue 8. [DOI: 10.1002/14651858.CD000490.pub3] ">Smaill 2015</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD000490-sec-0056" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD000490-sec-0056"></div> <p>To assess the effect of antibiotic treatment for asymptomatic bacteriuria on the development of pyelonephritis and the risk of low birthweight and preterm birth. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD000490-sec-0057" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD000490-sec-0057"></div> <section id="CD000490-sec-0058"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD000490-sec-0059"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials and quasi‐randomised trials (e.g. alternation). Cluster‐randomised trials were eligible for inclusion. Cross‐over trials were not eligible for inclusion. Trials published in abstract form only, or as a letter, were eligible for inclusion. </p> </section> <section id="CD000490-sec-0060"> <h4 class="title">Types of participants</h4> <p>Pregnant women found, on antenatal screening, to have asymptomatic bacteriuria, as defined by the study authors, at any stage of pregnancy. </p> </section> <section id="CD000490-sec-0061"> <h4 class="title">Types of interventions</h4> <p>We included studies if any antibiotic regimen was compared with placebo or no treatment for asymptomatic bacteriuria. </p> </section> <section id="CD000490-sec-0062"> <h4 class="title">Types of outcome measures</h4> <section id="CD000490-sec-0063"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD000490-list-0001"> <li> <p>Development of pyelonephritis</p> </li> <li> <p>Preterm birth less than 37 weeks</p> </li> <li> <p>Birthweight less than 2500 g</p> </li> </ol> </p> </section> <section id="CD000490-sec-0064"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD000490-list-0002"> <li> <p>Persistent bacteriuria</p> </li> <li> <p>Neonatal mortality or other serious adverse neonatal outcome</p> </li> <li> <p>Maternal side effects</p> </li> <li> <p>Costs, as defined by trial authors</p> </li> <li> <p>Birthweight</p> </li> <li> <p>Gestational age</p> </li> <li> <p>Women's satisfaction, as measured by trial authors</p> </li> </ol> </p> <p>Persistent bacteriuria was defined as bacteriuria persisting at the time of delivery.</p> <p>We used the World Health Organization's definition of prematurity: a baby born before 37 completed weeks of gestation (<a href="./references#CD000490-bbs2-0034" title="BlencoweH , CousensS , OestergaardMZ , ChouD , MollerA‐B , NarwalR , et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet2012;379:2161‐72. ">Blencowe 2012</a>). </p> </section> </section> </section> <section id="CD000490-sec-0065"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD000490-sec-0066"> <h4 class="title">Electronic searches</h4> <p>For this update, we searched Cochrane Pregnancy and Childbirth’s Trials Register, by contacting their Information Specialist (4 November 2018)<b>.</b> </p> <p>The Register is a database containing over 25,000 reports of controlled trials in the field of pregnancy and childbirth. It represents over 30 years of searching. For full, current search methods used to populate Pregnancy and Childbirth’s Trials Register, including the detailed search strategies for CENTRAL, MEDLINE, Embase, and CINAHL; the list of handsearched journals and conference proceedings; and the list of journals reviewed via the current awareness service; please follow this <a href="https://pregnancy.cochrane.org/pregnancy-and-childbirth-groups-trials-register" target="_blank">link</a>. </p> <p>Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is maintained by their Information Specialist, and contains trials identified from: </p> <p> <ol id="CD000490-list-0003"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE Ovid;</p> </li> <li> <p>weekly searches of Embase Ovid;</p> </li> <li> <p>monthly searches of CINAHL EBSCO;</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals, plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Search results are independently screened by two people, and the full text of all relevant trial reports identified through the searching activities described above is reviewed. Based on the intervention described, each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth review topic (or topics), and is then added to the Register. The Information Specialist searches the Register for each review using this topic number rather than keywords. This results in a more specific search set that has been fully accounted for in the relevant review sections (<a href="./references#CD000490-bbs1-0001" title="">Included studies</a>; <a href="./references#CD000490-bbs1-0002" title="">Excluded studies</a>; Studies awaiting classification; <a href="./references#CD000490-bbs1-0003" title="">Ongoing studies</a>). </p> <p>In addition, we searched <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> and the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) for unpublished, planned, and ongoing trial reports on 4 November 2018, using the search methods detailed in <a href="./appendices#CD000490-sec-0131">Appendix 1</a>. </p> </section> <section id="CD000490-sec-0067"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of retrieved studies.</p> <p>We did not apply any language or date restrictions.</p> </section> </section> <section id="CD000490-sec-0068"> <h3 class="title" id="CD000490-sec-0068">Data collection and analysis</h3> <p>For methods used in the previous versions of this review, <i>see</i><a href="./references#CD000490-bbs2-0096" title="SmaillF . Antibiotic vs no treatment for asymptomatic bacteriuria. [revised 22 April 1993]. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C editor(s). Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995. ">Smaill 1993</a>, <a href="./references#CD000490-bbs2-0098" title="SmaillFM , VazquezJC . Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database of Systematic Reviews2007, Issue 2. [DOI: 10.1002/14651858.CD000490.pub2] ">Smaill 2007</a> and <a href="./references#CD000490-bbs2-0099" title="SmaillFM , VazquezJC . Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database of Systematic Reviews2015, Issue 8. [DOI: 10.1002/14651858.CD000490.pub3] ">Smaill 2015</a>. </p> <p>For this update, we used the following methods to assess the reports that were identified as a result of the updated search, based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD000490-sec-0069"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed for inclusion all the potential studies identified as a result of the search strategy. We resolved any disagreement through discussion. </p> </section> <section id="CD000490-sec-0070"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data. If any new studies were included, both review authors independently extracted the data, using the agreed form. We resolved discrepancies through discussion. We entered data into Review Manager 5 software, and checked for accuracy (<a href="./references#CD000490-bbs2-0070" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). </p> <p>If information regarding any of the above had been unclear, we had planned to contact authors of the original reports to provide further details. </p> </section> <section id="CD000490-sec-0071"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias for each study, using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="http://archie.cochrane.org/sections/documents/view?version=z1212181516253162684622876719716%26format=REVMAN_GRAPHS#REF-Higgins-2011" target="_blank">Higgins 2011</a>). Any disagreement was resolved by discussion. </p> <section id="CD000490-sec-0072"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>For each included study, we described the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We assessed the method as:</p> <p> <ul id="CD000490-list-0004"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD000490-sec-0073"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>For each included study, we described the method used to conceal allocation to interventions prior to assignment, and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD000490-list-0005"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD000490-sec-0074"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>For each included study, we described the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding was unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as:</p> <p> <ul id="CD000490-list-0006"> <li> <p>low, high, or unclear risk of bias for participants;</p> </li> <li> <p>low, high, or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD000490-sec-0075"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>For each included study, we described the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed methods used to blind outcome assessment as:</p> <p> <ul id="CD000490-list-0007"> <li> <p>low, high, or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD000490-sec-0076"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>For each included study, and for each outcome or class of outcomes, we described the completeness of data, including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported, and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups, or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we planned to re‐include missing data in the analyses that we undertook. </p> <p>We assessed methods as:</p> <p> <ul id="CD000490-list-0008"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD000490-sec-0077"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>For each included study, we described how we investigated the possibility of selective outcome reporting bias, and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD000490-list-0009"> <li> <p>low risk of bias (where it was clear that all of the study’s prespecified outcomes and all expected outcomes of interest to the review had been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s prespecified outcomes had been reported; one or more reported primary outcomes were not prespecified; outcomes of interest were reported incompletely and so could not be used; study failed to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD000490-sec-0078"> <h5 class="title">(6) Other bias</h5> <p>Where identified, we described bias due to problems not covered elsewhere.</p> </section> <section id="CD000490-sec-0079"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD000490-bbs2-0049" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). With reference to (1) to (6) above, we planned to assess the likely magnitude and direction of the bias, and whether we considered it was likely to impact the findings. We planned to explore the impact of the level of bias by undertaking sensitivity analyses ‐ <i>see</i><a href="#CD000490-sec-0091">Sensitivity analysis</a>. </p> </section> <section id="CD000490-sec-0080"> <h5 class="title">Assessment of the quality of the evidence, using GRADE</h5> <p>For this update, we assessed the quality of the evidence using the GRADE approach (<a href="./references#CD000490-bbs2-0076" title="SchünemannHJ . GRADE: from grading the evidence to developing recommendations. A description of the system and a proposal regarding the transferability of the results of clinical research to clinical practice [GRADE: Von der Evidenz zur Empfehlung. Beschreibung des Systems und Losungsbeitrag zur Ubertragbarkeit von Studienergebnissen]. Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen2009;103(6):391‐400. ">Schünemann 2009</a>). We assessed the quality of the body of evidence relating to the following outcomes, for the main comparison of antibiotic versus no treatment. </p> <p> <ol id="CD000490-list-0010"> <li> <p>Development of pyelonephritis</p> </li> <li> <p>Preterm birth less than 37 weeks</p> </li> <li> <p>Birthweight less than 2500 g</p> </li> </ol> </p> <p>We used GRADEpro GDT software to import data from Review Manager 5 software, to create a ’Summary of findings’ table (<a href="./references#CD000490-bbs2-0044" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed Jan 27, 2019. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro GDT</a>; <a href="./references#CD000490-bbs2-0070" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). We produced a summary of the intervention effect and a measure of quality for each of the above outcomes, using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates, or potential publication bias. </p> </section> </section> <section id="CD000490-sec-0081"> <h4 class="title">Measures of treatment effect</h4> <section id="CD000490-sec-0082"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals. </p> </section> <section id="CD000490-sec-0083"> <h5 class="title">Continuous data</h5> <p>We used the mean difference if outcomes were measured in the same way between trials. In future updates, we plan to use the standardised mean difference to combine trials that measure the same outcome, but use different methods. </p> </section> </section> <section id="CD000490-sec-0084"> <h4 class="title">Unit of analysis issues</h4> <section id="CD000490-sec-0085"> <h5 class="title">Cluster‐randomised trials</h5> <p>If any were identified, we planned to include cluster‐randomised trials in the analyses along with individually‐randomised trials. In future updates of this review, if any cluster‐randomised trials are included, we will adjust their sample sizes using the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions, Section 16.3.4 or 16.3.6,</i> using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial, or from a study of a similar population. If we use ICCs from other sources, we will report this, and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster‐randomised trials and individually‐randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs, and the interaction between the effect of the intervention and the choice of randomisation unit is considered to be unlikely. </p> <p>We will also acknowledge heterogeneity in the randomisation unit, and perform a sensitivity analysis to investigate the effects of the randomisation unit. </p> </section> </section> <section id="CD000490-sec-0086"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, we noted levels of attrition. In future updates, if more eligible studies are included, we will explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect, by completing a sensitivity analysis. </p> <p>For all outcomes, we carried out analyses, as far as possible, on an intention‐to‐treat basis, and where reasonable, we attempted to include all participants randomised to each group in the analyses. </p> </section> <section id="CD000490-sec-0087"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the I² and Chi² statistics, and Tau². We regarded heterogeneity as substantial, if an I² was greater than 30%, and either a Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. If we identified substantial heterogeneity (above 30%), we explored it by prespecified subgroup analysis. </p> </section> <section id="CD000490-sec-0088"> <h4 class="title">Assessment of reporting biases</h4> <p>Where there were 10 or more studies in the meta‐analysis, we investigated reporting biases (such as publication bias) using funnel plots. We assessed funnel plot asymmetry visually, and at any suggestion of asymmetry, we planned to perform exploratory analyses to investigate it. </p> </section> <section id="CD000490-sec-0089"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using the Review Manager 5 software (<a href="./references#CD000490-bbs2-0070" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). We used fixed‐effect meta‐analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect, i.e. where trials were examining the same intervention, and the trials’ populations and methods were judged sufficiently similar. </p> <p>If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, we used random‐effects meta‐analysis to produce an overall summary, if an average treatment effect across trials was considered clinically meaningful. The random‐effects summary was treated as the average range of possible treatment effects, and we planned to discuss the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we would not have combined trials. Where we used random‐effects analyses, we presented the results as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I². </p> </section> <section id="CD000490-sec-0090"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If we identified substantial heterogeneity, we investigated it using subgroup analysis and sensitivity analysis. We considered whether an overall summary was meaningful, and if it was, we used random‐effects analysis to produce it. </p> <p>We carried out the following subgroup analysis to determine whether there was an effect of the duration of antibiotic therapy on the outcomes. </p> <p> <ol id="CD000490-list-0011"> <li> <p>Single dose versus no treatment</p> </li> <li> <p>Short course (three to seven days) versus no treatment</p> </li> <li> <p>Intermediate course (three to six weeks) versus no treatment</p> </li> <li> <p>Continuous antibiotic therapy until delivery versus no treatment</p> </li> </ol> </p> <p>We conducted subgroup analyses for the following outcomes.</p> <p> <ol id="CD000490-list-0012"> <li> <p>Development of pyelonephritis</p> </li> <li> <p>Preterm birth less than 37 weeks</p> </li> <li> <p>Birthweight less than 2500 g</p> </li> </ol> </p> <p>We assessed subgroup differences by interaction tests available within RevMan 5 (<a href="./references#CD000490-bbs2-0070" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). We reported the results of the subgroup analysis quoting the Chi² statistic and P value, and the interaction test I² value. </p> </section> <section id="CD000490-sec-0091"> <h4 class="title">Sensitivity analysis</h4> <p>We had planned to carry out sensitivity analysis to explore the effect of risk of bias on the overall results, by excluding studies where the overall risk of bias was high or there was insufficient detail provided to judge risk of bias from the analysis, for the primary outcomes. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD000490-sec-0092" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD000490-sec-0092"></div> <section id="CD000490-sec-0093"> <h3 class="title">Description of studies</h3> <section id="CD000490-sec-0094"> <h4 class="title">Results of the search</h4> <p>See: <a href="#CD000490-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD000490-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD000490-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> <p>We assessed four new trial reports (<a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>; <a href="./references#CD000490-bbs2-0019" title="NCT03274960 . The effect of screening and treatment of asymptomatic bacteriuria every trimester during pregnancy on incidence of preterm birth in Harare, Zimbabwe. clinicaltrials.gov/ct2/show/NCT03274960 (first received 7 September 2017). [NCT03274960] ">NCT03274960</a><i>;</i><a href="./references#CD000490-bbs2-0022" title="NCT03275623 . Management of sub‐clinical bacteriuria in pregnancy: a feasibility trial. clinicaltrials.gov/ct2/show/NCT03275623 (first received 7 September 2017). [NCT03275623] ">NCT03275623</a><i>;</i><a href="./references#CD000490-bbs2-0067" title="NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">NL2921</a>), and reassessed one trial report that was awaiting classification from the previous version of the review (<a href="./references#CD000490-bbs2-0056" title="KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. ">Kazemier 2012</a>). We excluded <a href="./references#CD000490-bbs2-0019" title="NCT03274960 . The effect of screening and treatment of asymptomatic bacteriuria every trimester during pregnancy on incidence of preterm birth in Harare, Zimbabwe. clinicaltrials.gov/ct2/show/NCT03274960 (first received 7 September 2017). [NCT03274960] ">NCT03274960</a> because the intervention was screening for asymptomatic bacteriuria versus no screening. <a href="./references#CD000490-bbs2-0022" title="NCT03275623 . Management of sub‐clinical bacteriuria in pregnancy: a feasibility trial. clinicaltrials.gov/ct2/show/NCT03275623 (first received 7 September 2017). [NCT03275623] ">NCT03275623</a> is a study of treatment versus no treatment for low level bacteriuria and is ongoing. We included one new study (<a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>). <a href="./references#CD000490-bbs2-0056" title="KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. ">Kazemier 2012</a> and <a href="./references#CD000490-bbs2-0067" title="NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">NL2921</a> are additional reports of that study. </p> </section> <section id="CD000490-sec-0095"> <h4 class="title">Included studies</h4> <p>We included 15 studies, in 22 reports, involving over 2000 women. For details, see <a href="./references#CD000490-sec-0146" title="">Characteristics of included studies</a>. One study enrolled only women with group B streptococci in the urine (<a href="./references#CD000490-bbs2-0013" title="ThomsenAC , MorupL , Brogaard HansenK . Antibiotic elimination of group‐B streptococci in urine in prevention of preterm labour. Lancet1987;1:591‐3. ">Thomsen 1987</a>). Where there was more than one published report that in the opinion of the review authors referred to the same study, we abstracted information from whichever report provided the most detailed information. The earliest published report was from 1960 (<a href="./references#CD000490-bbs2-0007" title="KassEH . Pyelonephritis and bacteriuria. A major problem in preventive medicine. Annals of Internal Medicine1962;56:46‐53. KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little Brown and Company, 1960:399‐412. SavageWE , HajjSN , KassEH . Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine (Baltimore)1967;46:385‐407. ZinnerSH , KassEH . Long term (10 to 14 years) follow‐up of bacteriuria of pregnancy. New England Journal of Medicine1971;285:820‐4. ">Kass 1960</a>), and the most recent from 2015 (<a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>). Most studies (N = 11) enrolled women prior to 1970. Only <a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a> reported any potential conflicts of interest. Two studies did not report a funding source (<a href="./references#CD000490-bbs2-0004" title="FoleyME , FarquharsonR , StrongeJM . Is screening for bacteriuria in pregnancy worthwhile?. British Medical Journal1987;295:270. ">Foley 1987</a>; <a href="./references#CD000490-bbs2-0011" title="MullaN . Bacteriuria in pregnancy. Obstetrics and Gynecology1960;16:89‐92. ">Mulla 1960</a>). Local or national research funding sources were reported for the majority of the other studies, and several studies described in‐kind support, where the antibiotic was provided by a pharmaceutical company. We did not find any cluster‐randomised trials. </p> <section id="CD000490-sec-0096"> <h5 class="title">Participants</h5> <p>Most women were enrolled from hospital‐based clinics in North America (<a href="./references#CD000490-bbs2-0002" title="ElderHA , SantamarinaBAG , SmithSA , KassEH . Use of sulfasymazine in the treatment of bacteriuria of pregnancy. Antimicrobial Agents and Chemotherapy1966;6:142‐8. ">Elder 1966</a>; <a href="./references#CD000490-bbs2-0003" title="ElderHA , SantamarinaBA , SmithSA , KassEH . Excess prematurity in tetracycline‐treated bacteriuric patients whose infection persisted or returned. Antimicrobial Agents and Chemotherapy1967;7:101‐9. ElderHA , SantamarinaBAG , SmithS , KassEH . The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. American Journal of Obstetrics and Gynecology1971;111:441‐62. ">Elder 1971</a>; <a href="./references#CD000490-bbs2-0006" title="GoldEM , TraubFB , DaichmanI , TerrisM . Asymptomatic bacteriuria during pregnancy. Obstetrics &amp; Gynecology1966;27:206‐9. ">Gold 1966</a>; <a href="./references#CD000490-bbs2-0007" title="KassEH . Pyelonephritis and bacteriuria. A major problem in preventive medicine. Annals of Internal Medicine1962;56:46‐53. KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little Brown and Company, 1960:399‐412. SavageWE , HajjSN , KassEH . Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine (Baltimore)1967;46:385‐407. ZinnerSH , KassEH . Long term (10 to 14 years) follow‐up of bacteriuria of pregnancy. New England Journal of Medicine1971;285:820‐4. ">Kass 1960</a>; <a href="./references#CD000490-bbs2-0011" title="MullaN . Bacteriuria in pregnancy. Obstetrics and Gynecology1960;16:89‐92. ">Mulla 1960</a>), the UK and Ireland (<a href="./references#CD000490-bbs2-0001" title="BrumfittW . The effects of bacteriuria in pregnancy on maternal and fetal health. Kidney International1975;8:S113‐9. CondieAP , WilliamsJD , ReevesDS , BrumfittW . Complications of bacteriuria in pregnancy. Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:148‐59. WilliamsJD , ReevesDS , CondieAP , FranklinISN , LeighDA , BrumfittW . The treatment of bacteriuria in pregnancy. In: O'GradyF , BrumfittW editor(s). Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:160‐9. ">Brumfitt 1975</a>; <a href="./references#CD000490-bbs2-0004" title="FoleyME , FarquharsonR , StrongeJM . Is screening for bacteriuria in pregnancy worthwhile?. British Medical Journal1987;295:270. ">Foley 1987</a>; <a href="./references#CD000490-bbs2-0010" title="LittlePJ . The incidence of urinary infection in 5000 pregnant women. Lancet1966;2:925‐8. ">Little 1966</a>; <a href="./references#CD000490-bbs2-0014" title="WilliamsGL , CampbellH , DaviesKJ . Urinary concentrating ability in women with asymptomatic bacteriuria in pregnancy. British Medical Journal1969;3:212‐5. ">Williams 1969</a>), and Australia (<a href="./references#CD000490-bbs2-0005" title="FurnessET , McDonaldPJ , BeasleyNV . Urinary antiseptics in asymptomatic bacteriuria of pregnancy. New Zealand Medical Journal1975;81:417‐9. ">Furness 1975</a>; <a href="./references#CD000490-bbs2-0009" title="Kincaid‐SmithP , BullenM . Bacteriuria in pregnancy. Lancet1965;1:1382‐7. ">Kincaid‐Smith 1965</a>; <a href="./references#CD000490-bbs2-0015" title="WrenBG . Subclinical renal infection and prematurity. Medical Journal of Australia1969;2:596‐600. ">Wren 1969</a>); the recent study from the Netherlands was set in the Dutch Obstetric Consortium, and enrolled women from university, teaching and non‐teaching hospitals, ultrasound centres, and midwifery practices (<a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>). </p> <p>The majority of studies enrolled women at the first antenatal visit (<a href="./references#CD000490-bbs2-0001" title="BrumfittW . The effects of bacteriuria in pregnancy on maternal and fetal health. Kidney International1975;8:S113‐9. CondieAP , WilliamsJD , ReevesDS , BrumfittW . Complications of bacteriuria in pregnancy. Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:148‐59. WilliamsJD , ReevesDS , CondieAP , FranklinISN , LeighDA , BrumfittW . The treatment of bacteriuria in pregnancy. In: O'GradyF , BrumfittW editor(s). Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:160‐9. ">Brumfitt 1975</a>; <a href="./references#CD000490-bbs2-0003" title="ElderHA , SantamarinaBA , SmithSA , KassEH . Excess prematurity in tetracycline‐treated bacteriuric patients whose infection persisted or returned. Antimicrobial Agents and Chemotherapy1967;7:101‐9. ElderHA , SantamarinaBAG , SmithS , KassEH . The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. American Journal of Obstetrics and Gynecology1971;111:441‐62. ">Elder 1971</a>; <a href="./references#CD000490-bbs2-0004" title="FoleyME , FarquharsonR , StrongeJM . Is screening for bacteriuria in pregnancy worthwhile?. British Medical Journal1987;295:270. ">Foley 1987</a>; <a href="./references#CD000490-bbs2-0007" title="KassEH . Pyelonephritis and bacteriuria. A major problem in preventive medicine. Annals of Internal Medicine1962;56:46‐53. KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little Brown and Company, 1960:399‐412. SavageWE , HajjSN , KassEH . Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine (Baltimore)1967;46:385‐407. ZinnerSH , KassEH . Long term (10 to 14 years) follow‐up of bacteriuria of pregnancy. New England Journal of Medicine1971;285:820‐4. ">Kass 1960</a>; <a href="./references#CD000490-bbs2-0009" title="Kincaid‐SmithP , BullenM . Bacteriuria in pregnancy. Lancet1965;1:1382‐7. ">Kincaid‐Smith 1965</a>; <a href="./references#CD000490-bbs2-0010" title="LittlePJ . The incidence of urinary infection in 5000 pregnant women. Lancet1966;2:925‐8. ">Little 1966</a>; <a href="./references#CD000490-bbs2-0014" title="WilliamsGL , CampbellH , DaviesKJ . Urinary concentrating ability in women with asymptomatic bacteriuria in pregnancy. British Medical Journal1969;3:212‐5. ">Williams 1969</a>; <a href="./references#CD000490-bbs2-0015" title="WrenBG . Subclinical renal infection and prematurity. Medical Journal of Australia1969;2:596‐600. ">Wren 1969</a>). Some studies enrolled women at the second antenatal visit (<a href="./references#CD000490-bbs2-0005" title="FurnessET , McDonaldPJ , BeasleyNV . Urinary antiseptics in asymptomatic bacteriuria of pregnancy. New Zealand Medical Journal1975;81:417‐9. ">Furness 1975</a>), between 16 and 22 weeks' gestation (<a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>), before 24 weeks (<a href="./references#CD000490-bbs2-0012" title="PathakUN , TangK , WilliamsLL , StuartKL . Bacteriuria of pregnancy: results of treatment. Journal of Infectious Diseases1969;120(1):91‐5. ">Pathak 1969</a>), between 27 and 31 weeks (<a href="./references#CD000490-bbs2-0013" title="ThomsenAC , MorupL , Brogaard HansenK . Antibiotic elimination of group‐B streptococci in urine in prevention of preterm labour. Lancet1987;1:591‐3. ">Thomsen 1987</a>), between 30 and 32 weeks (<a href="./references#CD000490-bbs2-0011" title="MullaN . Bacteriuria in pregnancy. Obstetrics and Gynecology1960;16:89‐92. ">Mulla 1960</a>), any gestational age &lt; 32 weeks (<a href="./references#CD000490-bbs2-0002" title="ElderHA , SantamarinaBAG , SmithSA , KassEH . Use of sulfasymazine in the treatment of bacteriuria of pregnancy. Antimicrobial Agents and Chemotherapy1966;6:142‐8. ">Elder 1966</a>), or at any prenatal visit (<a href="./references#CD000490-bbs2-0006" title="GoldEM , TraubFB , DaichmanI , TerrisM . Asymptomatic bacteriuria during pregnancy. Obstetrics &amp; Gynecology1966;27:206‐9. ">Gold 1966</a>). </p> <p>Two studies did not specify microbiological criteria for enrolment (<a href="./references#CD000490-bbs2-0001" title="BrumfittW . The effects of bacteriuria in pregnancy on maternal and fetal health. Kidney International1975;8:S113‐9. CondieAP , WilliamsJD , ReevesDS , BrumfittW . Complications of bacteriuria in pregnancy. Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:148‐59. WilliamsJD , ReevesDS , CondieAP , FranklinISN , LeighDA , BrumfittW . The treatment of bacteriuria in pregnancy. In: O'GradyF , BrumfittW editor(s). Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:160‐9. ">Brumfitt 1975</a>; <a href="./references#CD000490-bbs2-0011" title="MullaN . Bacteriuria in pregnancy. Obstetrics and Gynecology1960;16:89‐92. ">Mulla 1960</a>). Where there were microbiological criteria, bacteriuria was usually defined as at least one clean‐catch, midstream, or catheterised urine specimen with more than 100,000 bacteria/mL on culture. Some studies required one positive culture of &gt; 100,000 bacteria/mL (<a href="./references#CD000490-bbs2-0004" title="FoleyME , FarquharsonR , StrongeJM . Is screening for bacteriuria in pregnancy worthwhile?. British Medical Journal1987;295:270. ">Foley 1987</a>; <a href="./references#CD000490-bbs2-0005" title="FurnessET , McDonaldPJ , BeasleyNV . Urinary antiseptics in asymptomatic bacteriuria of pregnancy. New Zealand Medical Journal1975;81:417‐9. ">Furness 1975</a>; <a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>); several studies required confirmation with a second culture (<a href="./references#CD000490-bbs2-0005" title="FurnessET , McDonaldPJ , BeasleyNV . Urinary antiseptics in asymptomatic bacteriuria of pregnancy. New Zealand Medical Journal1975;81:417‐9. ">Furness 1975</a>; <a href="./references#CD000490-bbs2-0006" title="GoldEM , TraubFB , DaichmanI , TerrisM . Asymptomatic bacteriuria during pregnancy. Obstetrics &amp; Gynecology1966;27:206‐9. ">Gold 1966</a>; <a href="./references#CD000490-bbs2-0009" title="Kincaid‐SmithP , BullenM . Bacteriuria in pregnancy. Lancet1965;1:1382‐7. ">Kincaid‐Smith 1965</a>; <a href="./references#CD000490-bbs2-0010" title="LittlePJ . The incidence of urinary infection in 5000 pregnant women. Lancet1966;2:925‐8. ">Little 1966</a>; <a href="./references#CD000490-bbs2-0012" title="PathakUN , TangK , WilliamsLL , StuartKL . Bacteriuria of pregnancy: results of treatment. Journal of Infectious Diseases1969;120(1):91‐5. ">Pathak 1969</a>; <a href="./references#CD000490-bbs2-0014" title="WilliamsGL , CampbellH , DaviesKJ . Urinary concentrating ability in women with asymptomatic bacteriuria in pregnancy. British Medical Journal1969;3:212‐5. ">Williams 1969</a>; <a href="./references#CD000490-bbs2-0015" title="WrenBG . Subclinical renal infection and prematurity. Medical Journal of Australia1969;2:596‐600. ">Wren 1969</a>), and some required a third culture (<a href="./references#CD000490-bbs2-0002" title="ElderHA , SantamarinaBAG , SmithSA , KassEH . Use of sulfasymazine in the treatment of bacteriuria of pregnancy. Antimicrobial Agents and Chemotherapy1966;6:142‐8. ">Elder 1966</a>; <a href="./references#CD000490-bbs2-0003" title="ElderHA , SantamarinaBA , SmithSA , KassEH . Excess prematurity in tetracycline‐treated bacteriuric patients whose infection persisted or returned. Antimicrobial Agents and Chemotherapy1967;7:101‐9. ElderHA , SantamarinaBAG , SmithS , KassEH . The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. American Journal of Obstetrics and Gynecology1971;111:441‐62. ">Elder 1971</a>; <a href="./references#CD000490-bbs2-0007" title="KassEH . Pyelonephritis and bacteriuria. A major problem in preventive medicine. Annals of Internal Medicine1962;56:46‐53. KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little Brown and Company, 1960:399‐412. SavageWE , HajjSN , KassEH . Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine (Baltimore)1967;46:385‐407. ZinnerSH , KassEH . Long term (10 to 14 years) follow‐up of bacteriuria of pregnancy. New England Journal of Medicine1971;285:820‐4. ">Kass 1960</a>). One study included women with a lower colony count of more than 10,000 bacteria/mL on two occasions (<a href="./references#CD000490-bbs2-0005" title="FurnessET , McDonaldPJ , BeasleyNV . Urinary antiseptics in asymptomatic bacteriuria of pregnancy. New Zealand Medical Journal1975;81:417‐9. ">Furness 1975</a>); one enrolled women with any growth of group B streptococcus on a mid‐stream urine culture (<a href="./references#CD000490-bbs2-0013" title="ThomsenAC , MorupL , Brogaard HansenK . Antibiotic elimination of group‐B streptococci in urine in prevention of preterm labour. Lancet1987;1:591‐3. ">Thomsen 1987</a>). </p> </section> <section id="CD000490-sec-0097"> <h5 class="title">Interventions</h5> <p>Several different antibiotic regimens were used for treatment (<i>see</i><a href="./references#CD000490-sec-0146" title="">Characteristics of included studies</a> for details), including the study of group B streptococci<i>,</i> which compared penicillin to placebo (<a href="./references#CD000490-bbs2-0013" title="ThomsenAC , MorupL , Brogaard HansenK . Antibiotic elimination of group‐B streptococci in urine in prevention of preterm labour. Lancet1987;1:591‐3. ">Thomsen 1987</a>). Treatment varied as well; antibiotics were given in a single dose (<a href="./references#CD000490-bbs2-0001" title="BrumfittW . The effects of bacteriuria in pregnancy on maternal and fetal health. Kidney International1975;8:S113‐9. CondieAP , WilliamsJD , ReevesDS , BrumfittW . Complications of bacteriuria in pregnancy. Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:148‐59. WilliamsJD , ReevesDS , CondieAP , FranklinISN , LeighDA , BrumfittW . The treatment of bacteriuria in pregnancy. In: O'GradyF , BrumfittW editor(s). Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:160‐9. ">Brumfitt 1975</a>), for three to seven days (<a href="./references#CD000490-bbs2-0004" title="FoleyME , FarquharsonR , StrongeJM . Is screening for bacteriuria in pregnancy worthwhile?. British Medical Journal1987;295:270. ">Foley 1987</a>; <a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>; <a href="./references#CD000490-bbs2-0011" title="MullaN . Bacteriuria in pregnancy. Obstetrics and Gynecology1960;16:89‐92. ">Mulla 1960</a>; <a href="./references#CD000490-bbs2-0013" title="ThomsenAC , MorupL , Brogaard HansenK . Antibiotic elimination of group‐B streptococci in urine in prevention of preterm labour. Lancet1987;1:591‐3. ">Thomsen 1987</a>; <a href="./references#CD000490-bbs2-0014" title="WilliamsGL , CampbellH , DaviesKJ . Urinary concentrating ability in women with asymptomatic bacteriuria in pregnancy. British Medical Journal1969;3:212‐5. ">Williams 1969</a>), for three weeks (<a href="./references#CD000490-bbs2-0012" title="PathakUN , TangK , WilliamsLL , StuartKL . Bacteriuria of pregnancy: results of treatment. Journal of Infectious Diseases1969;120(1):91‐5. ">Pathak 1969</a>), for six weeks (<a href="./references#CD000490-bbs2-0003" title="ElderHA , SantamarinaBA , SmithSA , KassEH . Excess prematurity in tetracycline‐treated bacteriuric patients whose infection persisted or returned. Antimicrobial Agents and Chemotherapy1967;7:101‐9. ElderHA , SantamarinaBAG , SmithS , KassEH . The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. American Journal of Obstetrics and Gynecology1971;111:441‐62. ">Elder 1971</a>), continued until delivery (<a href="./references#CD000490-bbs2-0002" title="ElderHA , SantamarinaBAG , SmithSA , KassEH . Use of sulfasymazine in the treatment of bacteriuria of pregnancy. Antimicrobial Agents and Chemotherapy1966;6:142‐8. ">Elder 1966</a>; <a href="./references#CD000490-bbs2-0005" title="FurnessET , McDonaldPJ , BeasleyNV . Urinary antiseptics in asymptomatic bacteriuria of pregnancy. New Zealand Medical Journal1975;81:417‐9. ">Furness 1975</a>; <a href="./references#CD000490-bbs2-0006" title="GoldEM , TraubFB , DaichmanI , TerrisM . Asymptomatic bacteriuria during pregnancy. Obstetrics &amp; Gynecology1966;27:206‐9. ">Gold 1966</a>; <a href="./references#CD000490-bbs2-0007" title="KassEH . Pyelonephritis and bacteriuria. A major problem in preventive medicine. Annals of Internal Medicine1962;56:46‐53. KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little Brown and Company, 1960:399‐412. SavageWE , HajjSN , KassEH . Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine (Baltimore)1967;46:385‐407. ZinnerSH , KassEH . Long term (10 to 14 years) follow‐up of bacteriuria of pregnancy. New England Journal of Medicine1971;285:820‐4. ">Kass 1960</a>; <a href="./references#CD000490-bbs2-0009" title="Kincaid‐SmithP , BullenM . Bacteriuria in pregnancy. Lancet1965;1:1382‐7. ">Kincaid‐Smith 1965</a>), or up to six weeks after delivery (<a href="./references#CD000490-bbs2-0010" title="LittlePJ . The incidence of urinary infection in 5000 pregnant women. Lancet1966;2:925‐8. ">Little 1966</a>; <a href="./references#CD000490-bbs2-0015" title="WrenBG . Subclinical renal infection and prematurity. Medical Journal of Australia1969;2:596‐600. ">Wren 1969</a>). In four studies, a repeat antibiotic course with the same drug was administered if the infection persisted (<a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>; <a href="./references#CD000490-bbs2-0011" title="MullaN . Bacteriuria in pregnancy. Obstetrics and Gynecology1960;16:89‐92. ">Mulla 1960</a>; <a href="./references#CD000490-bbs2-0012" title="PathakUN , TangK , WilliamsLL , StuartKL . Bacteriuria of pregnancy: results of treatment. Journal of Infectious Diseases1969;120(1):91‐5. ">Pathak 1969</a>; <a href="./references#CD000490-bbs2-0013" title="ThomsenAC , MorupL , Brogaard HansenK . Antibiotic elimination of group‐B streptococci in urine in prevention of preterm labour. Lancet1987;1:591‐3. ">Thomsen 1987</a>). In several studies, an alternative agent was used for persisting or resistant organisms (<a href="./references#CD000490-bbs2-0004" title="FoleyME , FarquharsonR , StrongeJM . Is screening for bacteriuria in pregnancy worthwhile?. British Medical Journal1987;295:270. ">Foley 1987</a>; <a href="./references#CD000490-bbs2-0007" title="KassEH . Pyelonephritis and bacteriuria. A major problem in preventive medicine. Annals of Internal Medicine1962;56:46‐53. KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little Brown and Company, 1960:399‐412. SavageWE , HajjSN , KassEH . Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine (Baltimore)1967;46:385‐407. ZinnerSH , KassEH . Long term (10 to 14 years) follow‐up of bacteriuria of pregnancy. New England Journal of Medicine1971;285:820‐4. ">Kass 1960</a>; <a href="./references#CD000490-bbs2-0009" title="Kincaid‐SmithP , BullenM . Bacteriuria in pregnancy. Lancet1965;1:1382‐7. ">Kincaid‐Smith 1965</a>; <a href="./references#CD000490-bbs2-0010" title="LittlePJ . The incidence of urinary infection in 5000 pregnant women. Lancet1966;2:925‐8. ">Little 1966</a>; <a href="./references#CD000490-bbs2-0014" title="WilliamsGL , CampbellH , DaviesKJ . Urinary concentrating ability in women with asymptomatic bacteriuria in pregnancy. British Medical Journal1969;3:212‐5. ">Williams 1969</a>). Most studies used antibiotics that are no longer routinely used for treating bacteriuria, including certain sulphonamides (<a href="./references#CD000490-bbs2-0001" title="BrumfittW . The effects of bacteriuria in pregnancy on maternal and fetal health. Kidney International1975;8:S113‐9. CondieAP , WilliamsJD , ReevesDS , BrumfittW . Complications of bacteriuria in pregnancy. Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:148‐59. WilliamsJD , ReevesDS , CondieAP , FranklinISN , LeighDA , BrumfittW . The treatment of bacteriuria in pregnancy. In: O'GradyF , BrumfittW editor(s). Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:160‐9. ">Brumfitt 1975</a>; <a href="./references#CD000490-bbs2-0002" title="ElderHA , SantamarinaBAG , SmithSA , KassEH . Use of sulfasymazine in the treatment of bacteriuria of pregnancy. Antimicrobial Agents and Chemotherapy1966;6:142‐8. ">Elder 1966</a>; <a href="./references#CD000490-bbs2-0004" title="FoleyME , FarquharsonR , StrongeJM . Is screening for bacteriuria in pregnancy worthwhile?. British Medical Journal1987;295:270. ">Foley 1987</a>; <a href="./references#CD000490-bbs2-0006" title="GoldEM , TraubFB , DaichmanI , TerrisM . Asymptomatic bacteriuria during pregnancy. Obstetrics &amp; Gynecology1966;27:206‐9. ">Gold 1966</a>; <a href="./references#CD000490-bbs2-0007" title="KassEH . Pyelonephritis and bacteriuria. A major problem in preventive medicine. Annals of Internal Medicine1962;56:46‐53. KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little Brown and Company, 1960:399‐412. SavageWE , HajjSN , KassEH . Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine (Baltimore)1967;46:385‐407. ZinnerSH , KassEH . Long term (10 to 14 years) follow‐up of bacteriuria of pregnancy. New England Journal of Medicine1971;285:820‐4. ">Kass 1960</a>; <a href="./references#CD000490-bbs2-0009" title="Kincaid‐SmithP , BullenM . Bacteriuria in pregnancy. Lancet1965;1:1382‐7. ">Kincaid‐Smith 1965</a>; <a href="./references#CD000490-bbs2-0010" title="LittlePJ . The incidence of urinary infection in 5000 pregnant women. Lancet1966;2:925‐8. ">Little 1966</a>; <a href="./references#CD000490-bbs2-0011" title="MullaN . Bacteriuria in pregnancy. Obstetrics and Gynecology1960;16:89‐92. ">Mulla 1960</a>), tetracycline (<a href="./references#CD000490-bbs2-0003" title="ElderHA , SantamarinaBA , SmithSA , KassEH . Excess prematurity in tetracycline‐treated bacteriuric patients whose infection persisted or returned. Antimicrobial Agents and Chemotherapy1967;7:101‐9. ElderHA , SantamarinaBAG , SmithS , KassEH . The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. American Journal of Obstetrics and Gynecology1971;111:441‐62. ">Elder 1971</a>), and methenamine (<a href="./references#CD000490-bbs2-0005" title="FurnessET , McDonaldPJ , BeasleyNV . Urinary antiseptics in asymptomatic bacteriuria of pregnancy. New Zealand Medical Journal1975;81:417‐9. ">Furness 1975</a>). Some studies used nitrofurantoin, as either first line treatment (<a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>; <a href="./references#CD000490-bbs2-0010" title="LittlePJ . The incidence of urinary infection in 5000 pregnant women. Lancet1966;2:925‐8. ">Little 1966</a>; <a href="./references#CD000490-bbs2-0012" title="PathakUN , TangK , WilliamsLL , StuartKL . Bacteriuria of pregnancy: results of treatment. Journal of Infectious Diseases1969;120(1):91‐5. ">Pathak 1969</a>), or for failures (<a href="./references#CD000490-bbs2-0003" title="ElderHA , SantamarinaBA , SmithSA , KassEH . Excess prematurity in tetracycline‐treated bacteriuric patients whose infection persisted or returned. Antimicrobial Agents and Chemotherapy1967;7:101‐9. ElderHA , SantamarinaBAG , SmithS , KassEH . The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. American Journal of Obstetrics and Gynecology1971;111:441‐62. ">Elder 1971</a>; <a href="./references#CD000490-bbs2-0007" title="KassEH . Pyelonephritis and bacteriuria. A major problem in preventive medicine. Annals of Internal Medicine1962;56:46‐53. KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little Brown and Company, 1960:399‐412. SavageWE , HajjSN , KassEH . Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine (Baltimore)1967;46:385‐407. ZinnerSH , KassEH . Long term (10 to 14 years) follow‐up of bacteriuria of pregnancy. New England Journal of Medicine1971;285:820‐4. ">Kass 1960</a>; <a href="./references#CD000490-bbs2-0009" title="Kincaid‐SmithP , BullenM . Bacteriuria in pregnancy. Lancet1965;1:1382‐7. ">Kincaid‐Smith 1965</a>; <a href="./references#CD000490-bbs2-0010" title="LittlePJ . The incidence of urinary infection in 5000 pregnant women. Lancet1966;2:925‐8. ">Little 1966</a>; <a href="./references#CD000490-bbs2-0014" title="WilliamsGL , CampbellH , DaviesKJ . Urinary concentrating ability in women with asymptomatic bacteriuria in pregnancy. British Medical Journal1969;3:212‐5. ">Williams 1969</a>). In other studies, ampicillin was used for failures (<a href="./references#CD000490-bbs2-0009" title="Kincaid‐SmithP , BullenM . Bacteriuria in pregnancy. Lancet1965;1:1382‐7. ">Kincaid‐Smith 1965</a>; <a href="./references#CD000490-bbs2-0010" title="LittlePJ . The incidence of urinary infection in 5000 pregnant women. Lancet1966;2:925‐8. ">Little 1966</a>; <a href="./references#CD000490-bbs2-0014" title="WilliamsGL , CampbellH , DaviesKJ . Urinary concentrating ability in women with asymptomatic bacteriuria in pregnancy. British Medical Journal1969;3:212‐5. ">Williams 1969</a>). In one study, women received a fixed rotation of nitrofurantoin, ampicillin, sulphurazole, and nalidixic acid(<a href="./references#CD000490-bbs2-0015" title="WrenBG . Subclinical renal infection and prematurity. Medical Journal of Australia1969;2:596‐600. ">Wren 1969</a>). In only one study were data on antimicrobial susceptibility used to select the antibiotic (<a href="./references#CD000490-bbs2-0004" title="FoleyME , FarquharsonR , StrongeJM . Is screening for bacteriuria in pregnancy worthwhile?. British Medical Journal1987;295:270. ">Foley 1987</a>). </p> </section> <section id="CD000490-sec-0098"> <h5 class="title">Outcomes</h5> <p>Most studies (N = 12) included the outcome of pyelonephritis (<a href="./references#CD000490-bbs2-0001" title="BrumfittW . The effects of bacteriuria in pregnancy on maternal and fetal health. Kidney International1975;8:S113‐9. CondieAP , WilliamsJD , ReevesDS , BrumfittW . Complications of bacteriuria in pregnancy. Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:148‐59. WilliamsJD , ReevesDS , CondieAP , FranklinISN , LeighDA , BrumfittW . The treatment of bacteriuria in pregnancy. In: O'GradyF , BrumfittW editor(s). Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:160‐9. ">Brumfitt 1975</a>; <a href="./references#CD000490-bbs2-0003" title="ElderHA , SantamarinaBA , SmithSA , KassEH . Excess prematurity in tetracycline‐treated bacteriuric patients whose infection persisted or returned. Antimicrobial Agents and Chemotherapy1967;7:101‐9. ElderHA , SantamarinaBAG , SmithS , KassEH . The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. American Journal of Obstetrics and Gynecology1971;111:441‐62. ">Elder 1971</a>; <a href="./references#CD000490-bbs2-0004" title="FoleyME , FarquharsonR , StrongeJM . Is screening for bacteriuria in pregnancy worthwhile?. British Medical Journal1987;295:270. ">Foley 1987</a>; <a href="./references#CD000490-bbs2-0005" title="FurnessET , McDonaldPJ , BeasleyNV . Urinary antiseptics in asymptomatic bacteriuria of pregnancy. New Zealand Medical Journal1975;81:417‐9. ">Furness 1975</a>; <a href="./references#CD000490-bbs2-0006" title="GoldEM , TraubFB , DaichmanI , TerrisM . Asymptomatic bacteriuria during pregnancy. Obstetrics &amp; Gynecology1966;27:206‐9. ">Gold 1966</a>; <a href="./references#CD000490-bbs2-0007" title="KassEH . Pyelonephritis and bacteriuria. A major problem in preventive medicine. Annals of Internal Medicine1962;56:46‐53. KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little Brown and Company, 1960:399‐412. SavageWE , HajjSN , KassEH . Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine (Baltimore)1967;46:385‐407. ZinnerSH , KassEH . Long term (10 to 14 years) follow‐up of bacteriuria of pregnancy. New England Journal of Medicine1971;285:820‐4. ">Kass 1960</a>; <a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>; <a href="./references#CD000490-bbs2-0009" title="Kincaid‐SmithP , BullenM . Bacteriuria in pregnancy. Lancet1965;1:1382‐7. ">Kincaid‐Smith 1965</a>; <a href="./references#CD000490-bbs2-0010" title="LittlePJ . The incidence of urinary infection in 5000 pregnant women. Lancet1966;2:925‐8. ">Little 1966</a>; <a href="./references#CD000490-bbs2-0011" title="MullaN . Bacteriuria in pregnancy. Obstetrics and Gynecology1960;16:89‐92. ">Mulla 1960</a>; <a href="./references#CD000490-bbs2-0012" title="PathakUN , TangK , WilliamsLL , StuartKL . Bacteriuria of pregnancy: results of treatment. Journal of Infectious Diseases1969;120(1):91‐5. ">Pathak 1969</a>; <a href="./references#CD000490-bbs2-0014" title="WilliamsGL , CampbellH , DaviesKJ . Urinary concentrating ability in women with asymptomatic bacteriuria in pregnancy. British Medical Journal1969;3:212‐5. ">Williams 1969</a>). </p> <p>Six studies reported the outcome of birthweight &lt; 2500 g (<a href="./references#CD000490-bbs2-0001" title="BrumfittW . The effects of bacteriuria in pregnancy on maternal and fetal health. Kidney International1975;8:S113‐9. CondieAP , WilliamsJD , ReevesDS , BrumfittW . Complications of bacteriuria in pregnancy. Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:148‐59. WilliamsJD , ReevesDS , CondieAP , FranklinISN , LeighDA , BrumfittW . The treatment of bacteriuria in pregnancy. In: O'GradyF , BrumfittW editor(s). Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:160‐9. ">Brumfitt 1975</a>; <a href="./references#CD000490-bbs2-0003" title="ElderHA , SantamarinaBA , SmithSA , KassEH . Excess prematurity in tetracycline‐treated bacteriuric patients whose infection persisted or returned. Antimicrobial Agents and Chemotherapy1967;7:101‐9. ElderHA , SantamarinaBAG , SmithS , KassEH . The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. American Journal of Obstetrics and Gynecology1971;111:441‐62. ">Elder 1971</a>; <a href="./references#CD000490-bbs2-0007" title="KassEH . Pyelonephritis and bacteriuria. A major problem in preventive medicine. Annals of Internal Medicine1962;56:46‐53. KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little Brown and Company, 1960:399‐412. SavageWE , HajjSN , KassEH . Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine (Baltimore)1967;46:385‐407. ZinnerSH , KassEH . Long term (10 to 14 years) follow‐up of bacteriuria of pregnancy. New England Journal of Medicine1971;285:820‐4. ">Kass 1960</a>; <a href="./references#CD000490-bbs2-0009" title="Kincaid‐SmithP , BullenM . Bacteriuria in pregnancy. Lancet1965;1:1382‐7. ">Kincaid‐Smith 1965</a>; <a href="./references#CD000490-bbs2-0010" title="LittlePJ . The incidence of urinary infection in 5000 pregnant women. Lancet1966;2:925‐8. ">Little 1966</a>; <a href="./references#CD000490-bbs2-0015" title="WrenBG . Subclinical renal infection and prematurity. Medical Journal of Australia1969;2:596‐600. ">Wren 1969</a>). In many of the studies conducted during the 1960s, the standard definition of preterm birth was low birthweight, defined as birthweight less than 2500 g, rather than a gestational age less than 37 weeks. Two studies defined preterm birth as a gestational age of less than 37 weeks (<a href="./references#CD000490-bbs2-0013" title="ThomsenAC , MorupL , Brogaard HansenK . Antibiotic elimination of group‐B streptococci in urine in prevention of preterm labour. Lancet1987;1:591‐3. ">Thomsen 1987</a>; <a href="./references#CD000490-bbs2-0015" title="WrenBG . Subclinical renal infection and prematurity. Medical Journal of Australia1969;2:596‐600. ">Wren 1969</a>); <a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a> included results for gestational ages &lt; 37 weeks, &lt; 34 weeks, and &lt; 28 weeks. One study did not provide a definition of preterm birth (<a href="./references#CD000490-bbs2-0006" title="GoldEM , TraubFB , DaichmanI , TerrisM . Asymptomatic bacteriuria during pregnancy. Obstetrics &amp; Gynecology1966;27:206‐9. ">Gold 1966</a>), and <a href="./references#CD000490-bbs2-0005" title="FurnessET , McDonaldPJ , BeasleyNV . Urinary antiseptics in asymptomatic bacteriuria of pregnancy. New Zealand Medical Journal1975;81:417‐9. ">Furness 1975</a> used a definition of less than 38 weeks. While mean birthweight in the two groups were reported by <a href="./references#CD000490-bbs2-0001" title="BrumfittW . The effects of bacteriuria in pregnancy on maternal and fetal health. Kidney International1975;8:S113‐9. CondieAP , WilliamsJD , ReevesDS , BrumfittW . Complications of bacteriuria in pregnancy. Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:148‐59. WilliamsJD , ReevesDS , CondieAP , FranklinISN , LeighDA , BrumfittW . The treatment of bacteriuria in pregnancy. In: O'GradyF , BrumfittW editor(s). Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:160‐9. ">Brumfitt 1975</a>, <a href="./references#CD000490-bbs2-0003" title="ElderHA , SantamarinaBA , SmithSA , KassEH . Excess prematurity in tetracycline‐treated bacteriuric patients whose infection persisted or returned. Antimicrobial Agents and Chemotherapy1967;7:101‐9. ElderHA , SantamarinaBAG , SmithS , KassEH . The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. American Journal of Obstetrics and Gynecology1971;111:441‐62. ">Elder 1971</a>, <a href="./references#CD000490-bbs2-0005" title="FurnessET , McDonaldPJ , BeasleyNV . Urinary antiseptics in asymptomatic bacteriuria of pregnancy. New Zealand Medical Journal1975;81:417‐9. ">Furness 1975</a>, and <a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>, and mean gestational age by <a href="./references#CD000490-bbs2-0007" title="KassEH . Pyelonephritis and bacteriuria. A major problem in preventive medicine. Annals of Internal Medicine1962;56:46‐53. KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little Brown and Company, 1960:399‐412. SavageWE , HajjSN , KassEH . Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine (Baltimore)1967;46:385‐407. ZinnerSH , KassEH . Long term (10 to 14 years) follow‐up of bacteriuria of pregnancy. New England Journal of Medicine1971;285:820‐4. ">Kass 1960</a>, <a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>, and <a href="./references#CD000490-bbs2-0013" title="ThomsenAC , MorupL , Brogaard HansenK . Antibiotic elimination of group‐B streptococci in urine in prevention of preterm labour. Lancet1987;1:591‐3. ">Thomsen 1987</a>, not all authors reported the standard deviation of the mean, and we could not include these data in the analyses. </p> <p>Four studies defined persistent bacteriuria as a positive culture at delivery or the last prenatal visit (<a href="./references#CD000490-bbs2-0002" title="ElderHA , SantamarinaBAG , SmithSA , KassEH . Use of sulfasymazine in the treatment of bacteriuria of pregnancy. Antimicrobial Agents and Chemotherapy1966;6:142‐8. ">Elder 1966</a>; <a href="./references#CD000490-bbs2-0003" title="ElderHA , SantamarinaBA , SmithSA , KassEH . Excess prematurity in tetracycline‐treated bacteriuric patients whose infection persisted or returned. Antimicrobial Agents and Chemotherapy1967;7:101‐9. ElderHA , SantamarinaBAG , SmithS , KassEH . The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. American Journal of Obstetrics and Gynecology1971;111:441‐62. ">Elder 1971</a>; <a href="./references#CD000490-bbs2-0006" title="GoldEM , TraubFB , DaichmanI , TerrisM . Asymptomatic bacteriuria during pregnancy. Obstetrics &amp; Gynecology1966;27:206‐9. ">Gold 1966</a>; <a href="./references#CD000490-bbs2-0012" title="PathakUN , TangK , WilliamsLL , StuartKL . Bacteriuria of pregnancy: results of treatment. Journal of Infectious Diseases1969;120(1):91‐5. ">Pathak 1969</a>); two defined it as a positive culture at six weeks to three months postpartum (<a href="./references#CD000490-bbs2-0005" title="FurnessET , McDonaldPJ , BeasleyNV . Urinary antiseptics in asymptomatic bacteriuria of pregnancy. New Zealand Medical Journal1975;81:417‐9. ">Furness 1975</a>; <a href="./references#CD000490-bbs2-0009" title="Kincaid‐SmithP , BullenM . Bacteriuria in pregnancy. Lancet1965;1:1382‐7. ">Kincaid‐Smith 1965</a>); one did not define it (<a href="./references#CD000490-bbs2-0004" title="FoleyME , FarquharsonR , StrongeJM . Is screening for bacteriuria in pregnancy worthwhile?. British Medical Journal1987;295:270. ">Foley 1987</a>). Three studies also measured long‐term rates of bacteriuria: one between three and nine months postpartum (<a href="./references#CD000490-bbs2-0012" title="PathakUN , TangK , WilliamsLL , StuartKL . Bacteriuria of pregnancy: results of treatment. Journal of Infectious Diseases1969;120(1):91‐5. ">Pathak 1969</a>), one at six months (<a href="./references#CD000490-bbs2-0009" title="Kincaid‐SmithP , BullenM . Bacteriuria in pregnancy. Lancet1965;1:1382‐7. ">Kincaid‐Smith 1965</a>), and one at 10 to 14 years (<a href="./references#CD000490-bbs2-0007" title="KassEH . Pyelonephritis and bacteriuria. A major problem in preventive medicine. Annals of Internal Medicine1962;56:46‐53. KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little Brown and Company, 1960:399‐412. SavageWE , HajjSN , KassEH . Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine (Baltimore)1967;46:385‐407. ZinnerSH , KassEH . Long term (10 to 14 years) follow‐up of bacteriuria of pregnancy. New England Journal of Medicine1971;285:820‐4. ">Kass 1960</a>). </p> <p>Only two studies specifically commented on maternal side effects: <a href="./references#CD000490-bbs2-0011" title="MullaN . Bacteriuria in pregnancy. Obstetrics and Gynecology1960;16:89‐92. ">Mulla 1960</a> stated there were no side effects necessitating discontinuation of treatment, and <a href="./references#CD000490-bbs2-0006" title="GoldEM , TraubFB , DaichmanI , TerrisM . Asymptomatic bacteriuria during pregnancy. Obstetrics &amp; Gynecology1966;27:206‐9. ">Gold 1966</a> reported "no toxic manifestations in women in the treatment group". </p> <p>Neonatal mortality or other serious adverse neonatal outcomes were incompletely reported, and there were no standard definitions. Neonatal deaths were reported by <a href="./references#CD000490-bbs2-0003" title="ElderHA , SantamarinaBA , SmithSA , KassEH . Excess prematurity in tetracycline‐treated bacteriuric patients whose infection persisted or returned. Antimicrobial Agents and Chemotherapy1967;7:101‐9. ElderHA , SantamarinaBAG , SmithS , KassEH . The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. American Journal of Obstetrics and Gynecology1971;111:441‐62. ">Elder 1971</a> and <a href="./references#CD000490-bbs2-0007" title="KassEH . Pyelonephritis and bacteriuria. A major problem in preventive medicine. Annals of Internal Medicine1962;56:46‐53. KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little Brown and Company, 1960:399‐412. SavageWE , HajjSN , KassEH . Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine (Baltimore)1967;46:385‐407. ZinnerSH , KassEH . Long term (10 to 14 years) follow‐up of bacteriuria of pregnancy. New England Journal of Medicine1971;285:820‐4. ">Kass 1960</a>, and <a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a> defined and reported on severe neonatal morbidity (presence of one or more of the following: severe respiratory distress syndrome, bronchopulmonary dysplasia, periventricular leukomalacia &gt; grade 1, intracerebral haemorrhage &gt; grade 2, necrotizing enterocolitis &gt; grade 1, or proven sepsis). </p> <p>No studies reported on women's satisfaction with the intervention.</p> </section> </section> <section id="CD000490-sec-0099"> <h4 class="title">Excluded studies</h4> <p>Six studies, in seven reports, were excluded because they did not meet the inclusion criteria. In one study, we could not ascertain whether the women had been randomly allocated to treatment or no treatment (<a href="./references#CD000490-bbs2-0016" title="Calderon‐JaimesEC , Arredondo‐GarciaJLA , Olvera‐SalinasJO , Echaniz‐AvilesGE , Conde‐GonzalezCC , Hernandez‐NevarezPH . Urinary infection prevention during pregnancy in patients with asymptomatic bacteriuria. Ginecologia y Obstetricia de Mexico1989;57:90‐7. ">Calderon‐Jaimes 1989</a>), and <a href="./references#CD000490-bbs2-0018" title="MohammadM , MahdyZA , OmarJ , MaanN , JamilMA . Laboratory aspects of asymptomatic bacteriuria in pregnancy. Southeast Asian Journal of Tropical Medicine and Public Health2002;33(3):575‐80. ">Mohammad 2002</a> was an observational study, with no treatment intervention. In <a href="./references#CD000490-bbs2-0021" title="SandersonP , MendayP . Pivmecillinam for bacteriuria in pregnancy. Journal of Antimicrobial Chemotherapy1984;13:383‐8. ">Sanderson 1984</a>, only women who had been successfully treated initially were randomised to continue treatment. <a href="./references#CD000490-bbs2-0017" title="LeBlancAL , McGanityWJ . The impact of bacteriuria in pregnancy ‐ a survey of 1300 pregnant patients. Biologie Medicale1964;22:336‐47. ">LeBlanc 1964</a> included symptomatic women in the outcomes; the asymptomatic group was not reported separately. The intervention in <a href="./references#CD000490-bbs2-0019" title="NCT03274960 . The effect of screening and treatment of asymptomatic bacteriuria every trimester during pregnancy on incidence of preterm birth in Harare, Zimbabwe. clinicaltrials.gov/ct2/show/NCT03274960 (first received 7 September 2017). [NCT03274960] ">NCT03274960</a> was screening versus no screening, rather than treatment versus no treatment, and the women in <a href="./references#CD000490-bbs2-0020" title="Rafal'skiiVV , Dovgan'EV , KozyrevIuV , GustovarovaTA , KhlybovaSV , NovoselovaAV , et al. The efficacy and safety of cefixime and amoxicillin/clavulanate in the treatment of asymptomatic bacteriuria in pregnant women: a randomized, prospective, multicenter study. Urologiia2013;5(24):26‐8. RafalskiyV , DovganE , KozyrevY , GustovarovaT , KhlybovaS , NovoselovaA , et al. Cefixime vs. amoxicillin/clavulanate in pregnant women with asymptomatic bacteriuria: Multicentre randomised study. Clinical Microbiology and Infection2012;18(Suppl s3):425‐6. ">Rafalskiy 2013</a> were randomised to one of two treatment groups, without a no treatment group. S<i>ee</i><a href="./references#CD000490-sec-0147" title="">Characteristics of excluded studies</a> table for details. </p> </section> </section> <section id="CD000490-sec-0100"> <h3 class="title">Risk of bias in included studies</h3> <p>For most studies, there was only a brief and incomplete description of the research methods, which made it difficult to assess the risk of bias in the studies. <a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a> described the methods in detail, and published the study protocol. </p> <p>See <a href="#CD000490-fig-0002">Figure 2</a>. The description of the characteristics of the study groups was generally poor. In only one study, were the similarities in age, parity, and socioeconomic status between the treatment and no treatment groups adequately described (<a href="./references#CD000490-bbs2-0013" title="ThomsenAC , MorupL , Brogaard HansenK . Antibiotic elimination of group‐B streptococci in urine in prevention of preterm labour. Lancet1987;1:591‐3. ">Thomsen 1987</a>); <a href="./references#CD000490-bbs2-0055" title="KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little, Brown and Co, 1960:399‐412. ">Kass 1960a</a> described the racial distribution of the two groups, which was comparable; in four other studies, the urinary bacterial isolates for the two groups were listed (<a href="./references#CD000490-bbs2-0002" title="ElderHA , SantamarinaBAG , SmithSA , KassEH . Use of sulfasymazine in the treatment of bacteriuria of pregnancy. Antimicrobial Agents and Chemotherapy1966;6:142‐8. ">Elder 1966</a>; <a href="./references#CD000490-bbs2-0003" title="ElderHA , SantamarinaBA , SmithSA , KassEH . Excess prematurity in tetracycline‐treated bacteriuric patients whose infection persisted or returned. Antimicrobial Agents and Chemotherapy1967;7:101‐9. ElderHA , SantamarinaBAG , SmithS , KassEH . The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. American Journal of Obstetrics and Gynecology1971;111:441‐62. ">Elder 1971</a>; <a href="./references#CD000490-bbs2-0006" title="GoldEM , TraubFB , DaichmanI , TerrisM . Asymptomatic bacteriuria during pregnancy. Obstetrics &amp; Gynecology1966;27:206‐9. ">Gold 1966</a>; <a href="./references#CD000490-bbs2-0011" title="MullaN . Bacteriuria in pregnancy. Obstetrics and Gynecology1960;16:89‐92. ">Mulla 1960</a>), but otherwise, there was no attempt to demonstrate the comparability of the study groups. <a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a> described the baseline characteristics of the study populations, including age, body mass index, education level, smoking status, alcohol use, parity, pre‐existing hypertension, gestational age at screening, and pregnancy occurring after fertility treatment, but included the untreated group (N = 163) with the women given placebo (N = 45) in the comparison with the asymptomatic bacteriuria‐positive women who received nitrofurantoin. No other study included the rates of maternal smoking, a recognised risk for low birthweight. There was no description of the presence of co‐existing genital infections, although one study excluded women with positive serology for syphilis (<a href="./references#CD000490-bbs2-0012" title="PathakUN , TangK , WilliamsLL , StuartKL . Bacteriuria of pregnancy: results of treatment. Journal of Infectious Diseases1969;120(1):91‐5. ">Pathak 1969</a>). Details on the management of recurrent urinary tract infection or persistent infection, the treatment of symptomatic lower urinary tract infection (cystitis), and concurrent antibiotic administration were generally incomplete. Some studies included twin deliveries, while other studies excluded these. </p> <div class="figure" id="CD000490-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study" data-id="CD000490-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> </div> <p>There was no consistent application of standard definitions for the measured outcomes. Pyelonephritis usually referred to symptoms of loin pain, fever, dysuria, or frequency, with or without a significant urine culture. While rates of low birthweight were usually reported, most studies described this as prematurity. For studies that reported rates of preterm births, the definition of preterm birth was inconsistent, and there were insufficient data presented in most of the studies to compare gestational ages and birthweight between treatment and control groups. </p> <section id="CD000490-sec-0101"> <h4 class="title">Allocation</h4> <p>In only one study was group assignment based on a web‐based application with a computer‐generated list (<a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>); in another study, the random component in the sequence generation was described as a coin toss (<a href="./references#CD000490-bbs2-0004" title="FoleyME , FarquharsonR , StrongeJM . Is screening for bacteriuria in pregnancy worthwhile?. British Medical Journal1987;295:270. ">Foley 1987</a>). For the other studies, there was either no description of the method of randomisation, or the method was clearly inadequate: in four studies, women were allocated to treatment by alternation, so we assessed them at high risk of bias (<a href="./references#CD000490-bbs2-0003" title="ElderHA , SantamarinaBA , SmithSA , KassEH . Excess prematurity in tetracycline‐treated bacteriuric patients whose infection persisted or returned. Antimicrobial Agents and Chemotherapy1967;7:101‐9. ElderHA , SantamarinaBAG , SmithS , KassEH . The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. American Journal of Obstetrics and Gynecology1971;111:441‐62. ">Elder 1971</a>; <a href="./references#CD000490-bbs2-0006" title="GoldEM , TraubFB , DaichmanI , TerrisM . Asymptomatic bacteriuria during pregnancy. Obstetrics &amp; Gynecology1966;27:206‐9. ">Gold 1966</a>; <a href="./references#CD000490-bbs2-0007" title="KassEH . Pyelonephritis and bacteriuria. A major problem in preventive medicine. Annals of Internal Medicine1962;56:46‐53. KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little Brown and Company, 1960:399‐412. SavageWE , HajjSN , KassEH . Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine (Baltimore)1967;46:385‐407. ZinnerSH , KassEH . Long term (10 to 14 years) follow‐up of bacteriuria of pregnancy. New England Journal of Medicine1971;285:820‐4. ">Kass 1960</a>; <a href="./references#CD000490-bbs2-0015" title="WrenBG . Subclinical renal infection and prematurity. Medical Journal of Australia1969;2:596‐600. ">Wren 1969</a>). </p> <p>In the majority of studies, there was inadequate description of concealment of allocation to judge selection bias. One study referred to the use of sealed envelopes, but the envelope was drawn from a pool of sealed envelopes rather than a consecutively numbered pile, so we assessed this study as unclear risk of bias (<a href="./references#CD000490-bbs2-0010" title="LittlePJ . The incidence of urinary infection in 5000 pregnant women. Lancet1966;2:925‐8. ">Little 1966</a>). One study described allocation as centrally controlled (<a href="./references#CD000490-bbs2-0009" title="Kincaid‐SmithP , BullenM . Bacteriuria in pregnancy. Lancet1965;1:1382‐7. ">Kincaid‐Smith 1965</a>); the remaining studies made no such statement. </p> </section> <section id="CD000490-sec-0102"> <h4 class="title">Blinding</h4> <p>In 10 of the 15 studies, the control group received a placebo (<a href="./references#CD000490-bbs2-0001" title="BrumfittW . The effects of bacteriuria in pregnancy on maternal and fetal health. Kidney International1975;8:S113‐9. CondieAP , WilliamsJD , ReevesDS , BrumfittW . Complications of bacteriuria in pregnancy. Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:148‐59. WilliamsJD , ReevesDS , CondieAP , FranklinISN , LeighDA , BrumfittW . The treatment of bacteriuria in pregnancy. In: O'GradyF , BrumfittW editor(s). Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:160‐9. ">Brumfitt 1975</a>; <a href="./references#CD000490-bbs2-0002" title="ElderHA , SantamarinaBAG , SmithSA , KassEH . Use of sulfasymazine in the treatment of bacteriuria of pregnancy. Antimicrobial Agents and Chemotherapy1966;6:142‐8. ">Elder 1966</a>; <a href="./references#CD000490-bbs2-0003" title="ElderHA , SantamarinaBA , SmithSA , KassEH . Excess prematurity in tetracycline‐treated bacteriuric patients whose infection persisted or returned. Antimicrobial Agents and Chemotherapy1967;7:101‐9. ElderHA , SantamarinaBAG , SmithS , KassEH . The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. American Journal of Obstetrics and Gynecology1971;111:441‐62. ">Elder 1971</a>; <a href="./references#CD000490-bbs2-0006" title="GoldEM , TraubFB , DaichmanI , TerrisM . Asymptomatic bacteriuria during pregnancy. Obstetrics &amp; Gynecology1966;27:206‐9. ">Gold 1966</a>; <a href="./references#CD000490-bbs2-0007" title="KassEH . Pyelonephritis and bacteriuria. A major problem in preventive medicine. Annals of Internal Medicine1962;56:46‐53. KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little Brown and Company, 1960:399‐412. SavageWE , HajjSN , KassEH . Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine (Baltimore)1967;46:385‐407. ZinnerSH , KassEH . Long term (10 to 14 years) follow‐up of bacteriuria of pregnancy. New England Journal of Medicine1971;285:820‐4. ">Kass 1960</a>; <a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>; <a href="./references#CD000490-bbs2-0009" title="Kincaid‐SmithP , BullenM . Bacteriuria in pregnancy. Lancet1965;1:1382‐7. ">Kincaid‐Smith 1965</a>; <a href="./references#CD000490-bbs2-0010" title="LittlePJ . The incidence of urinary infection in 5000 pregnant women. Lancet1966;2:925‐8. ">Little 1966</a>; <a href="./references#CD000490-bbs2-0012" title="PathakUN , TangK , WilliamsLL , StuartKL . Bacteriuria of pregnancy: results of treatment. Journal of Infectious Diseases1969;120(1):91‐5. ">Pathak 1969</a>; <a href="./references#CD000490-bbs2-0013" title="ThomsenAC , MorupL , Brogaard HansenK . Antibiotic elimination of group‐B streptococci in urine in prevention of preterm labour. Lancet1987;1:591‐3. ">Thomsen 1987</a>). Two of these studies were described as placebo‐controlled, without any further details (<a href="./references#CD000490-bbs2-0006" title="GoldEM , TraubFB , DaichmanI , TerrisM . Asymptomatic bacteriuria during pregnancy. Obstetrics &amp; Gynecology1966;27:206‐9. ">Gold 1966</a>; <a href="./references#CD000490-bbs2-0010" title="LittlePJ . The incidence of urinary infection in 5000 pregnant women. Lancet1966;2:925‐8. ">Little 1966</a>); four of the studies were described as double‐blinded, again, without further details (<a href="./references#CD000490-bbs2-0001" title="BrumfittW . The effects of bacteriuria in pregnancy on maternal and fetal health. Kidney International1975;8:S113‐9. CondieAP , WilliamsJD , ReevesDS , BrumfittW . Complications of bacteriuria in pregnancy. Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:148‐59. WilliamsJD , ReevesDS , CondieAP , FranklinISN , LeighDA , BrumfittW . The treatment of bacteriuria in pregnancy. In: O'GradyF , BrumfittW editor(s). Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:160‐9. ">Brumfitt 1975</a>; <a href="./references#CD000490-bbs2-0002" title="ElderHA , SantamarinaBAG , SmithSA , KassEH . Use of sulfasymazine in the treatment of bacteriuria of pregnancy. Antimicrobial Agents and Chemotherapy1966;6:142‐8. ">Elder 1966</a>; <a href="./references#CD000490-bbs2-0012" title="PathakUN , TangK , WilliamsLL , StuartKL . Bacteriuria of pregnancy: results of treatment. Journal of Infectious Diseases1969;120(1):91‐5. ">Pathak 1969</a>; <a href="./references#CD000490-bbs2-0013" title="ThomsenAC , MorupL , Brogaard HansenK . Antibiotic elimination of group‐B streptococci in urine in prevention of preterm labour. Lancet1987;1:591‐3. ">Thomsen 1987</a>); and <a href="./references#CD000490-bbs2-0003" title="ElderHA , SantamarinaBA , SmithSA , KassEH . Excess prematurity in tetracycline‐treated bacteriuric patients whose infection persisted or returned. Antimicrobial Agents and Chemotherapy1967;7:101‐9. ElderHA , SantamarinaBAG , SmithS , KassEH . The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. American Journal of Obstetrics and Gynecology1971;111:441‐62. ">Elder 1971</a> reported the placebo was 'identical appearing'. However there was insufficient information provided in the reports of these seven studies to know whether the blinding could have been broken, and therefore, we classified them at unclear risk of bias. In three studies, there was a specific mention that neither the women nor treating physician was aware of allocation to treatment group, and we judged them at low risk of performance bias (<a href="./references#CD000490-bbs2-0007" title="KassEH . Pyelonephritis and bacteriuria. A major problem in preventive medicine. Annals of Internal Medicine1962;56:46‐53. KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little Brown and Company, 1960:399‐412. SavageWE , HajjSN , KassEH . Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine (Baltimore)1967;46:385‐407. ZinnerSH , KassEH . Long term (10 to 14 years) follow‐up of bacteriuria of pregnancy. New England Journal of Medicine1971;285:820‐4. ">Kass 1960</a>; <a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>; <a href="./references#CD000490-bbs2-0009" title="Kincaid‐SmithP , BullenM . Bacteriuria in pregnancy. Lancet1965;1:1382‐7. ">Kincaid‐Smith 1965</a>). No treatment was given to the control group in the other five studies, so we judged them at high risk of bias, given the outcomes may have been influenced by lack of blinding (<a href="./references#CD000490-bbs2-0004" title="FoleyME , FarquharsonR , StrongeJM . Is screening for bacteriuria in pregnancy worthwhile?. British Medical Journal1987;295:270. ">Foley 1987</a>; <a href="./references#CD000490-bbs2-0005" title="FurnessET , McDonaldPJ , BeasleyNV . Urinary antiseptics in asymptomatic bacteriuria of pregnancy. New Zealand Medical Journal1975;81:417‐9. ">Furness 1975</a>; <a href="./references#CD000490-bbs2-0011" title="MullaN . Bacteriuria in pregnancy. Obstetrics and Gynecology1960;16:89‐92. ">Mulla 1960</a>; <a href="./references#CD000490-bbs2-0014" title="WilliamsGL , CampbellH , DaviesKJ . Urinary concentrating ability in women with asymptomatic bacteriuria in pregnancy. British Medical Journal1969;3:212‐5. ">Williams 1969</a>; <a href="./references#CD000490-bbs2-0015" title="WrenBG . Subclinical renal infection and prematurity. Medical Journal of Australia1969;2:596‐600. ">Wren 1969</a>). </p> <p>Only <a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a> specifically commented that the researchers remained blind to group allocation, although in <a href="./references#CD000490-bbs2-0009" title="Kincaid‐SmithP , BullenM . Bacteriuria in pregnancy. Lancet1965;1:1382‐7. ">Kincaid‐Smith 1965</a>, it was reported that "a code of instructions to the pharmacist ensured that the trial remained double‐blind..." We judged these two studies at low risk of detection bias. Although four of the studies were described as double‐blinded, there were insufficient details provided to know whether indeed the outcome assessment was blinded (<a href="./references#CD000490-bbs2-0001" title="BrumfittW . The effects of bacteriuria in pregnancy on maternal and fetal health. Kidney International1975;8:S113‐9. CondieAP , WilliamsJD , ReevesDS , BrumfittW . Complications of bacteriuria in pregnancy. Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:148‐59. WilliamsJD , ReevesDS , CondieAP , FranklinISN , LeighDA , BrumfittW . The treatment of bacteriuria in pregnancy. In: O'GradyF , BrumfittW editor(s). Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:160‐9. ">Brumfitt 1975</a>; <a href="./references#CD000490-bbs2-0002" title="ElderHA , SantamarinaBAG , SmithSA , KassEH . Use of sulfasymazine in the treatment of bacteriuria of pregnancy. Antimicrobial Agents and Chemotherapy1966;6:142‐8. ">Elder 1966</a>; <a href="./references#CD000490-bbs2-0012" title="PathakUN , TangK , WilliamsLL , StuartKL . Bacteriuria of pregnancy: results of treatment. Journal of Infectious Diseases1969;120(1):91‐5. ">Pathak 1969</a>; <a href="./references#CD000490-bbs2-0013" title="ThomsenAC , MorupL , Brogaard HansenK . Antibiotic elimination of group‐B streptococci in urine in prevention of preterm labour. Lancet1987;1:591‐3. ">Thomsen 1987</a>). We judged these four studies, along with the other nine studies where no information was provided, at unclear risk of bias. However, it is likely that in the five studies where there was no use of placebo, the risk of detection bias was high. </p> </section> <section id="CD000490-sec-0103"> <h4 class="title">Incomplete outcome data</h4> <p>We judged seven studies as low risk for attrition bias: in four studies, there was no loss to follow‐up and outcomes were reported for all enrolled women (<a href="./references#CD000490-bbs2-0006" title="GoldEM , TraubFB , DaichmanI , TerrisM . Asymptomatic bacteriuria during pregnancy. Obstetrics &amp; Gynecology1966;27:206‐9. ">Gold 1966</a>; <a href="./references#CD000490-bbs2-0010" title="LittlePJ . The incidence of urinary infection in 5000 pregnant women. Lancet1966;2:925‐8. ">Little 1966</a>; <a href="./references#CD000490-bbs2-0011" title="MullaN . Bacteriuria in pregnancy. Obstetrics and Gynecology1960;16:89‐92. ">Mulla 1960</a>; <a href="./references#CD000490-bbs2-0013" title="ThomsenAC , MorupL , Brogaard HansenK . Antibiotic elimination of group‐B streptococci in urine in prevention of preterm labour. Lancet1987;1:591‐3. ">Thomsen 1987</a>); in two studies, information was provided on women lost to follow‐up, and missing outcome data were reasonably balanced across groups (<a href="./references#CD000490-bbs2-0002" title="ElderHA , SantamarinaBAG , SmithSA , KassEH . Use of sulfasymazine in the treatment of bacteriuria of pregnancy. Antimicrobial Agents and Chemotherapy1966;6:142‐8. ">Elder 1966</a>; <a href="./references#CD000490-bbs2-0012" title="PathakUN , TangK , WilliamsLL , StuartKL . Bacteriuria of pregnancy: results of treatment. Journal of Infectious Diseases1969;120(1):91‐5. ">Pathak 1969</a>), and in <a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>, five women, enrolled in error, were included in the intention‐to‐treat analysis. We judged five studies to have high risk of attrition bias, given that the missing data may have introduced a clinically important effect on the estimate of treatment. There was no explanation provided for missing outcome data in four studies (<a href="./references#CD000490-bbs2-0001" title="BrumfittW . The effects of bacteriuria in pregnancy on maternal and fetal health. Kidney International1975;8:S113‐9. CondieAP , WilliamsJD , ReevesDS , BrumfittW . Complications of bacteriuria in pregnancy. Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:148‐59. WilliamsJD , ReevesDS , CondieAP , FranklinISN , LeighDA , BrumfittW . The treatment of bacteriuria in pregnancy. In: O'GradyF , BrumfittW editor(s). Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:160‐9. ">Brumfitt 1975</a>; <a href="./references#CD000490-bbs2-0004" title="FoleyME , FarquharsonR , StrongeJM . Is screening for bacteriuria in pregnancy worthwhile?. British Medical Journal1987;295:270. ">Foley 1987</a>; <a href="./references#CD000490-bbs2-0005" title="FurnessET , McDonaldPJ , BeasleyNV . Urinary antiseptics in asymptomatic bacteriuria of pregnancy. New Zealand Medical Journal1975;81:417‐9. ">Furness 1975</a>; <a href="./references#CD000490-bbs2-0007" title="KassEH . Pyelonephritis and bacteriuria. A major problem in preventive medicine. Annals of Internal Medicine1962;56:46‐53. KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little Brown and Company, 1960:399‐412. SavageWE , HajjSN , KassEH . Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine (Baltimore)1967;46:385‐407. ZinnerSH , KassEH . Long term (10 to 14 years) follow‐up of bacteriuria of pregnancy. New England Journal of Medicine1971;285:820‐4. ">Kass 1960</a>), while in <a href="./references#CD000490-bbs2-0009" title="Kincaid‐SmithP , BullenM . Bacteriuria in pregnancy. Lancet1965;1:1382‐7. ">Kincaid‐Smith 1965</a>, outcomes were not reported for women excluded because of poor compliance. In three studies, we were unclear about the risk of attrition bias: there was no explanation for the differences in group sizes in <a href="./references#CD000490-bbs2-0014" title="WilliamsGL , CampbellH , DaviesKJ . Urinary concentrating ability in women with asymptomatic bacteriuria in pregnancy. British Medical Journal1969;3:212‐5. ">Williams 1969</a>, and while the reasons for excluding women were provided in two studies, details on the allocation group were not (<a href="./references#CD000490-bbs2-0003" title="ElderHA , SantamarinaBA , SmithSA , KassEH . Excess prematurity in tetracycline‐treated bacteriuric patients whose infection persisted or returned. Antimicrobial Agents and Chemotherapy1967;7:101‐9. ElderHA , SantamarinaBAG , SmithS , KassEH . The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. American Journal of Obstetrics and Gynecology1971;111:441‐62. ">Elder 1971</a>; <a href="./references#CD000490-bbs2-0015" title="WrenBG . Subclinical renal infection and prematurity. Medical Journal of Australia1969;2:596‐600. ">Wren 1969</a>). </p> </section> <section id="CD000490-sec-0104"> <h4 class="title">Selective reporting</h4> <p>In only one study was a study protocol published and the study's prespecified outcomes reported; we judged this study at low risk of selective reporting bias (<a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>). For several studies, pregnancy outcomes of interest were either not reported (<a href="./references#CD000490-bbs2-0002" title="ElderHA , SantamarinaBAG , SmithSA , KassEH . Use of sulfasymazine in the treatment of bacteriuria of pregnancy. Antimicrobial Agents and Chemotherapy1966;6:142‐8. ">Elder 1966</a>; <a href="./references#CD000490-bbs2-0004" title="FoleyME , FarquharsonR , StrongeJM . Is screening for bacteriuria in pregnancy worthwhile?. British Medical Journal1987;295:270. ">Foley 1987</a>; <a href="./references#CD000490-bbs2-0011" title="MullaN . Bacteriuria in pregnancy. Obstetrics and Gynecology1960;16:89‐92. ">Mulla 1960</a>; <a href="./references#CD000490-bbs2-0012" title="PathakUN , TangK , WilliamsLL , StuartKL . Bacteriuria of pregnancy: results of treatment. Journal of Infectious Diseases1969;120(1):91‐5. ">Pathak 1969</a>; <a href="./references#CD000490-bbs2-0014" title="WilliamsGL , CampbellH , DaviesKJ . Urinary concentrating ability in women with asymptomatic bacteriuria in pregnancy. British Medical Journal1969;3:212‐5. ">Williams 1969</a>), or there was no definition of prematurity (<a href="./references#CD000490-bbs2-0006" title="GoldEM , TraubFB , DaichmanI , TerrisM . Asymptomatic bacteriuria during pregnancy. Obstetrics &amp; Gynecology1966;27:206‐9. ">Gold 1966</a>); we judged these studies at high risk of reporting bias. We judged studies that failed to include the primary outcome of pyelonephritis (<a href="./references#CD000490-bbs2-0001" title="BrumfittW . The effects of bacteriuria in pregnancy on maternal and fetal health. Kidney International1975;8:S113‐9. CondieAP , WilliamsJD , ReevesDS , BrumfittW . Complications of bacteriuria in pregnancy. Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:148‐59. WilliamsJD , ReevesDS , CondieAP , FranklinISN , LeighDA , BrumfittW . The treatment of bacteriuria in pregnancy. In: O'GradyF , BrumfittW editor(s). Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:160‐9. ">Brumfitt 1975</a>; <a href="./references#CD000490-bbs2-0002" title="ElderHA , SantamarinaBAG , SmithSA , KassEH . Use of sulfasymazine in the treatment of bacteriuria of pregnancy. Antimicrobial Agents and Chemotherapy1966;6:142‐8. ">Elder 1966</a>; <a href="./references#CD000490-bbs2-0015" title="WrenBG . Subclinical renal infection and prematurity. Medical Journal of Australia1969;2:596‐600. ">Wren 1969</a>), studies where the outcome of pyelonephritis in pregnancy was not reported for all women allocated to treatment (<a href="./references#CD000490-bbs2-0001" title="BrumfittW . The effects of bacteriuria in pregnancy on maternal and fetal health. Kidney International1975;8:S113‐9. CondieAP , WilliamsJD , ReevesDS , BrumfittW . Complications of bacteriuria in pregnancy. Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:148‐59. WilliamsJD , ReevesDS , CondieAP , FranklinISN , LeighDA , BrumfittW . The treatment of bacteriuria in pregnancy. In: O'GradyF , BrumfittW editor(s). Urinary Tract Infection, Proceedings of the First National Symposium. London: Oxford University Press, 1968:160‐9. ">Brumfitt 1975</a>; <a href="./references#CD000490-bbs2-0005" title="FurnessET , McDonaldPJ , BeasleyNV . Urinary antiseptics in asymptomatic bacteriuria of pregnancy. New Zealand Medical Journal1975;81:417‐9. ">Furness 1975</a>), or those in which there was no clear definition of pyelonephritis (<a href="./references#CD000490-bbs2-0004" title="FoleyME , FarquharsonR , StrongeJM . Is screening for bacteriuria in pregnancy worthwhile?. British Medical Journal1987;295:270. ">Foley 1987</a>; <a href="./references#CD000490-bbs2-0007" title="KassEH . Pyelonephritis and bacteriuria. A major problem in preventive medicine. Annals of Internal Medicine1962;56:46‐53. KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little Brown and Company, 1960:399‐412. SavageWE , HajjSN , KassEH . Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine (Baltimore)1967;46:385‐407. ZinnerSH , KassEH . Long term (10 to 14 years) follow‐up of bacteriuria of pregnancy. New England Journal of Medicine1971;285:820‐4. ">Kass 1960</a>; <a href="./references#CD000490-bbs2-0011" title="MullaN . Bacteriuria in pregnancy. Obstetrics and Gynecology1960;16:89‐92. ">Mulla 1960</a>), at high risk of reporting bias. For the remaining four studies, there was insufficient information to permit judgement; we classified these as unclear. </p> </section> <section id="CD000490-sec-0105"> <h4 class="title">Other potential sources of bias</h4> <p>We did not identify any other obvious sources of bias, and so we judged this category at low risk, for each of the studies. </p> <section id="CD000490-sec-0106"> <h5 class="title">Overall risk of bias</h5> <p>We judged five studies at high overall risk of overall bias (<a href="./references#CD000490-bbs2-0003" title="ElderHA , SantamarinaBA , SmithSA , KassEH . Excess prematurity in tetracycline‐treated bacteriuric patients whose infection persisted or returned. Antimicrobial Agents and Chemotherapy1967;7:101‐9. ElderHA , SantamarinaBAG , SmithS , KassEH . The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. American Journal of Obstetrics and Gynecology1971;111:441‐62. ">Elder 1971</a>; <a href="./references#CD000490-bbs2-0004" title="FoleyME , FarquharsonR , StrongeJM . Is screening for bacteriuria in pregnancy worthwhile?. British Medical Journal1987;295:270. ">Foley 1987</a>; <a href="./references#CD000490-bbs2-0005" title="FurnessET , McDonaldPJ , BeasleyNV . Urinary antiseptics in asymptomatic bacteriuria of pregnancy. New Zealand Medical Journal1975;81:417‐9. ">Furness 1975</a>; <a href="./references#CD000490-bbs2-0014" title="WilliamsGL , CampbellH , DaviesKJ . Urinary concentrating ability in women with asymptomatic bacteriuria in pregnancy. British Medical Journal1969;3:212‐5. ">Williams 1969</a>; <a href="./references#CD000490-bbs2-0015" title="WrenBG . Subclinical renal infection and prematurity. Medical Journal of Australia1969;2:596‐600. ">Wren 1969</a>), and one study at low overall risk (<a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>). While we assessed the overall risk of bias as unclear for the other nine studies, we assessed at least one domain at high risk of bias in each of these studies. </p> </section> </section> </section> <section id="CD000490-sec-0107"> <h3 class="title" id="CD000490-sec-0107">Effects of interventions</h3> <p>See: <a href="./full#CD000490-tbl-0001"><b>Summary of findings for the main comparison</b> Antibiotics compared to no treatment for asymptomatic bacteriuria in pregnancy</a> </p> <section id="CD000490-sec-0108"> <h4 class="title">1. Antibiotics versus no treatment for asymptomatic bacteriuria</h4> <section id="CD000490-sec-0109"> <h5 class="title">Primary outcomes</h5> <p>Antibiotic treatment may reduce the incidence of pyelonephritis in women with asymptomatic bacteriuria (average risk ratio (RR) 0.24, 95% confidence interval (CI) 0.13 to 0.41; 12 studies, 2017 women; I² = 60%; low‐certainty evidence; <a href="./references#CD000490-fig-0004" title="">Analysis 1.1</a>). There was significant heterogeneity among the studies, and we used a random‐effects analysis. For most studies, a beneficial effect was seen with treatment. We assessed reporting biases (such as publication bias) using a funnel plot. There was no strong evidence of funnel plot asymmetry by visual assessment (<a href="#CD000490-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD000490-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Antibiotic versus no treatment for asymptomatic bacteriuria, outcome: 1.1 Development of pyelonephritis" data-id="CD000490-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Antibiotic versus no treatment for asymptomatic bacteriuria, outcome: 1.1 Development of pyelonephritis </p> </div> </div> </div> <p>Antibiotic treatment may reduce the incidence of preterm birth, when this was defined as a gestational age of less than 37 weeks (RR 0.34, 95% CI 0.13 to 0.88; 3 studies, 327 women; I² = 32%; low‐certainty evidence; <a href="./references#CD000490-fig-0005" title="">Analysis 1.2</a>; <a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>; <a href="./references#CD000490-bbs2-0013" title="ThomsenAC , MorupL , Brogaard HansenK . Antibiotic elimination of group‐B streptococci in urine in prevention of preterm labour. Lancet1987;1:591‐3. ">Thomsen 1987</a>; <a href="./references#CD000490-bbs2-0015" title="WrenBG . Subclinical renal infection and prematurity. Medical Journal of Australia1969;2:596‐600. ">Wren 1969</a>). <a href="./references#CD000490-bbs2-0013" title="ThomsenAC , MorupL , Brogaard HansenK . Antibiotic elimination of group‐B streptococci in urine in prevention of preterm labour. Lancet1987;1:591‐3. ">Thomsen 1987</a> only enrolled women with group B streptococcal bacteriuria. </p> <p>Antibiotic treatment may reduce the incidence of birthweight less than 2500 g (average RR 0.64, 95% CI 0.45 to 0.93; 6 studies, 1437 babies; I² = 28%; low‐certainty evidence; <a href="./references#CD000490-fig-0006" title="">Analysis 1.3</a>). </p> <p>We used a random‐effects meta‐analysis for preterm birth and low birthweight because we predicted there would be real differences in treatment effect from study to study given the clinically important differences in study populations and interventions. </p> </section> <section id="CD000490-sec-0110"> <h5 class="title">Secondary outcomes</h5> <p>Antibiotic treatment is probably effective in clearing asymptomatic bacteriuria (average RR 0.30, 95% CI 0.18 to 0.53; 4 studies, 596 women; I² = 76%; <a href="./references#CD000490-fig-0007" title="">Analysis 1.4</a>). Without treatment, bacteriuria was present at the time of delivery in 66% of women. Although there was significant statistical heterogeneity among trials, likely explained by differences in study design and intervention, the direction of the effect was consistent. Treatment with antibiotics probably has no effect on the long‐term incidence of bacteriuria (one study reported results at between three and nine months postpartum, one reported at six months, and one at 10 to 14 years). </p> <p>It is uncertain whether antibiotic treatment has any effect on serious adverse neonatal outcomes, because there was insufficient information from a small number of trials with few events (RR 0.64, 95% CI 0.23 to 1.79; 3 studies, 549 babies; <a href="./references#CD000490-fig-0008" title="">Analysis 1.5</a>). </p> <p>Information on maternal adverse events was incompletely reported and we could not analyse the results. </p> <p>There were too few studies that reported on mean birthweight and gestational age for us to draw any conclusions. The results were inconclusive for mean birthweight (mean difference (MD) 21.03, 95% CI ‐83.65 to 125.70; 2 studies, 495 babies; <a href="./references#CD000490-fig-0009" title="">Analysis 1.6</a>), and mean gestational age (MD 1.00, 95% CI 0.01 to 1.99; 1 study, 203 babies; <a href="./references#CD000490-fig-0010" title="">Analysis 1.7</a>) </p> <p>None of the studies measured cost or women's satisfaction with the treatment.</p> </section> </section> <section id="CD000490-sec-0111"> <h4 class="title">2. Antibiotic treatment versus no treatment: subgroups by duration of treatment</h4> <p>There was a reduction in the incidence of pyelonephritis for all subgroups, regardless of duration of treatment (<a href="./references#CD000490-fig-0004" title="">Analysis 1.1</a>) </p> <p>There were too few studies to make a meaningful interpretation of the effect of duration of treatment on the risk of preterm birth (<a href="./references#CD000490-fig-0005" title="">Analysis 1.2</a>). </p> <p>On visual inspection of the graphs, it appeared that there was a difference in the incidence of low birthweight with duration of treatment although the interaction test did not suggest a difference (test for subgroup differences: Chi² = 2.82, df = 2 (P = 0.24), I² = 29.1%; <a href="./references#CD000490-fig-0006" title="">Analysis 1.3</a>), and there were too few studies to be confident that a longer duration of therapy was associated with a better outcome. </p> <p>We judged that in all but one of the studies the overall risk of bias was low; therefore, we did not perform a sensitivity analysis based on risk of bias. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD000490-sec-0112" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD000490-sec-0112"></div> <section id="CD000490-sec-0113"> <h3 class="title" id="CD000490-sec-0113">Summary of main results</h3> <p>While the results of these studies are consistent, suggesting there may be a reduction in the incidence of pyelonephritis, low birthweight, and preterm birth with treatment of asymptomatic bacteriuria, these conclusions are based on low‐certainty evidence. There was significant heterogeneity observed among the studies, which may be explained by study design or quality, type of antibiotic used, and the changes in obstetrical practice in the past five decades between the earliest and the latest study. Duration of antibiotic treatment did not appear to explain any heterogeneity. </p> <p>The overall incidence of pyelonephritis in the untreated group was 20%, but ranged from 2.2% to 36%. While different definitions of pyelonephritis could explain some of this variation, there may be other factors, for example, type of infecting organism, socioeconomic status, other care given in pregnancy, which if defined, could identify groups of women with asymptomatic bacteriuria with different risks of developing pyelonephritis. However, in the absence of this type of information, the presence of asymptomatic bacteriuria itself defines a population at risk of pyelonephritis. </p> </section> <section id="CD000490-sec-0114"> <h3 class="title" id="CD000490-sec-0114">Overall completeness and applicability of evidence</h3> <p>The studies reported here (with only three exceptions) date from the 1960s and 1970s; microbiological methodology for the diagnosis of bacteriuria has not significantly changed over this interval. Although not all of the antibiotics used in these studies remain available currently, and the use of tetracycline is now contraindicated in pregnancy, it is valid to assume that the results are applicable to other antibiotics active against urinary pathogens that are safe in pregnancy. A Cochrane Review of treatments for symptomatic urinary tract infections during pregnancy concluded that although antibiotic treatment is probably effective for the cure of urinary tract infections, there are insufficient data to recommend any specific regimen (<a href="./references#CD000490-bbs2-0086" title="VazquezJC , AbalosE . Treatments for symptomatic urinary tract infections during pregnancy. Cochrane Database of Systematic Reviews2011, Issue 1. [DOI: 10.1002/14651858.CD002256.pub2] ">Vazquez 2011</a>); there were similar conclusions for the treatment of asymptomatic bacteriuria (<a href="./references#CD000490-bbs2-0045" title="GuintoVT , DeGuiaB , FestinMR , DowswellT . Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy. Cochrane Database of Systematic Reviews2010, Issue 9. [DOI: 10.1002/14651858.CD007855.pub2] ">Guinto 2010</a>). The choice of a sulphonamide or sulphonamide‐containing combination, a penicillin, cephalosporin, fosfomycin, or nitrofurantoin, based on the results of susceptibility testing, may be appropriate regimens for the management of asymptomatic bacteriuria. However, increasing antibiotic resistance complicates the choice of empiric regimens, and can make it difficult to select an appropriate regimen (<a href="./references#CD000490-bbs2-0029" title="AssefaA , AsratD , WoldeamanuelY , G/HiwotY , AbdellaA , MelesseT . Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at Tikur Anbessa Specialized Hospital Addis Ababa, Ethiopia. Ethiopian Medical Journal2008;46(3):227‐35. ">Assefa 2008</a>; <a href="./references#CD000490-bbs2-0038" title="EnayatK , FaribaF , BahramN . Asymptomatic bacteriuria among pregnant women referred to outpatient clinics in Sanandaj, Iran. International Brazilian Journal of Urology2008;34(6):699‐704. ">Enayat 2008</a>; <a href="./references#CD000490-bbs2-0048" title="Hernandez BlasF , Lopez CarmonaJM , Rodriguez MoctezumaJR , Peralta PedreroML , Rodriguez GulierrezRS , Ortiz AguirreAR . Asymptomatic bacteriuria frequency in pregnant women and uropathogen in vitro antimicrobial sensitivity. Ginecologia y Obstetricia de Mexico2007;75(6):325‐31. ">Hernandez Blas 2007</a>; <a href="./references#CD000490-bbs2-0082" title="TadessE , TeshomeM , MeridY , KibretB , ShimelisT . Asymptomatic urinary tract infection among pregnant women attending the antenatal clinic of Hawassa Referral Hospital, Southern Ethiopia. BMC Research Notes2014;17(7):155. ">Tadesse 2014</a>). In India, the presence of extended‐spectrum ß‐lactamases (ESBL), making the strain resistant to all penicillins and cephalosporins, was described in 47% of isolates of <i>E coli,</i> and 36.9% of isolates of <i>Klebsiella pneumoniae</i> (<a href="./references#CD000490-bbs2-0071" title="RizviM , KhanF , ShuklaI , MalikA , ShaheenMA . Rising prevalence of antimicrobial resistance in urinary tract infections during pregnancy: necessity for exploring newer treatment options. Journal of Laboratory Physicians2011;3(2):98‐103. ">Rizvi 2011</a>). However, a recent case‐control study from Israel reported no difference in obstetric outcomes between women with bacteriuria caused by ESBL versus non‐ESBL isolates of Enterobacteriaceae (<a href="./references#CD000490-bbs2-0095" title="YagelY , NatiyH , RiesenbergK , NesherL , Saidel‐OdesL , SmolyakovR . Outcomes of UTI and bacteriuria caused by ESBL vs. non‐ESBL enterobacteriaceae isolates in pregnancy: a matched case‐control study. Epidemiology and Infection2018;146(6):771‐4. ">Yagel 2018</a>). Surveys of antibiotic susceptibility in pathogens causing community‐acquired uncomplicated urinary tract infections demonstrate considerable regional variation: resistance to ampicillin in <i>E. coli</i> in a survey of European countries and Canada averaged 29.8%, but was as high as 53.9% in Spain (<a href="./references#CD000490-bbs2-0053" title="KahlmeterG . An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. Journal of Antimicrobial Chemotherapy2003;51:69‐76. ">Kahlmeter 2003</a>). In the most recent study, 99% of the strains of <i>E. coli</i> from a low‐risk population of pregnant women in the Netherlands were sensitive to nitrofurantoin (<a href="./references#CD000490-bbs2-0008" title="KazemierBM , KoningsteinFN , SchneebergerC , OttA , BossuytPM , deMirandaE , et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases2015;15(11):1324‐33. KazemierBM , SchneebergerC , DeMirandaE , VanWassenaerA , BossuytPM , VogelvangTE , et al. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth2012;12:52. NL2921 . ASB treat study: costs and effects of screening and treating healthy women for asymptomatic bacteriuria. www.trialregister.nl/trial/2921 (first received 5 September 2011). [NTR3068] ">Kazemier 2015</a>), </p> <p>Both continuous treatment and short‐course therapy strategies may show a benefit in the reduction of pyelonephritis. A small randomised study that compared intermittent therapy with continuous treatment suggested that both strategies may be equally effective (<a href="./references#CD000490-bbs2-0089" title="WhalleyPJ , CunninghamFG . Short‐term versus continuous antimicrobial therapy for asymptomatic bacteriuria in pregnancy. Obstetrics and Gynecology1977;49:262‐5. ">Whalley 1977</a>). While short‐course therapy of asymptomatic bacteriuria has become accepted practice, the optimal duration of treatment is unknown; a three to seven day treatment regimen is currently recommended (<a href="./references#CD000490-bbs2-0091" title="WidmerM , GulmezogluAM , MigniniL , RogantiA . Duration of treatment for asymptomatic bacteriuria during pregnancy. Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD000491.pub2] ">Widmer 2011</a>). </p> <p>There may be an association between antibiotic treatment and preterm birth (low‐certainty evidence), but only three studies reported this outcome, one of which only included women with group B streptococcus bacteriuria. Although we chose to combine data from the three studies, given the very different populations and interventions, the effect of treatment on preterm birth is very uncertain. While preterm births are associated with low birthweight, some low birthweight infants are small‐for‐gestational age as a consequence of intrauterine growth retardation, for which there are many possible etiologies. The reduction in the incidence of low birthweight with antibiotic treatment of asymptomatic bacteriuria is consistent with current theories about the role of infection as a cause of adverse pregnancy outcomes, but a greater understanding of the basic mechanisms by which the treatment of bacteriuria could lead to a reduction in low birthweight is required. Prevention of pyelonephritis, which in studies conducted prior to the availability of effective antimicrobial therapy was associated with preterm birth, may be a factor, but treatment of bacteriuria with antibiotics may also eradicate organisms colonizing the cervix and vagina that are associated with adverse pregnancy outcomes. The relationship between genital infections, such as bacterial vaginosis, and preterm labor was not recognised when most of these studies on the treatment of asymptomatic bacteriuria were originally designed. </p> </section> <section id="CD000490-sec-0115"> <h3 class="title" id="CD000490-sec-0115">Quality of the evidence</h3> <p>We assessed and rated the quality of the evidence for the three primary outcomes using GRADEpro GDT software and the GRADE approach. See <a href="./full#CD000490-tbl-0001">summary of findings Table for the main comparison</a>. We rated the evidence for pyelonephritis as low certainty; the certainty of the evidence was downgraded by important design limitations leading to a high risk of bias (including lack of allocation concealment and blinding) and inconsistency (heterogeneity in the results and important differences in the population and intervention). We rated the evidence for preterm birth and for birthweight less than 2500 g as low certainty. For preterm birth, there were important differences in the population and intervention, and in one of the studies contributing data, important design limitations. For birthweight less than 2500 g, there were important design limitations (including lack of allocation concealment and blinding) and differences in the intervention. </p> <p>Many of the studies only contributed data to one or two of the outcomes; data are missing for most of the outcomes. Most studies did include the outcome of pyelonephritis. When these studies were being designed, there was already an awareness of a possible association between asymptomatic bacteriuria and low birthweight and preterm birth (<a href="./references#CD000490-bbs2-0055" title="KassEH . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: QuinnEL , KassEH editor(s). Biology of Pyelonephritis. Boston: Little, Brown and Co, 1960:399‐412. ">Kass 1960a</a>), but we found no explanation for why these outcomes were not systematically collected and reported in most of the trials. None of the studies systematically collected or reported the adverse effects of antibiotics. They neither systematically collected the incidence of allergic reactions, vaginal yeast infections, gastrointestinal side effects, or the development of bacterial resistance, nor did they systematically collect neonatal outcomes. While it is not possible to compare the benefits versus the disadvantages of antibiotic therapy from these studies, it is unlikely that the expected side effects from a short course of antibiotics would be significant, although increasingly, there are concerns about the effect of antibiotics on the human microbiome and the developing immune system. </p> </section> <section id="CD000490-sec-0116"> <h3 class="title" id="CD000490-sec-0116">Potential biases in the review process</h3> <p>The inclusion criteria for this review were broad, and included any antibiotic regimen, with the aim of being able to include all of the possible evidence, but this did lead to trials that differed in important ways, in respect to the treatment intervention, which could not be resolved by subgroup analysis. </p> <p>We acknowledge that there was the potential for bias in the reviewing process. For the earliest iterations of this review, there was no predefined protocol, and the methods for including trials, extracting data, and assessing bias were not well described. However, we did address this in later versions of the review, by ensuring two authors independently assessed all the studies for inclusion, extracted data, and assessed risk of bias. But updates to the review cannot be done blinded to the knowledge of previous outcomes, and although the review has become more methodologically robust, there remains the potential to introduce subjective and unconscious biases. </p> </section> <section id="CD000490-sec-0117"> <h3 class="title" id="CD000490-sec-0117">Agreements and disagreements with other studies or reviews</h3> <p>Results of a meta‐analysis of 17 cohort studies showed an association between asymptomatic bacteriuria and low birthweight and preterm birth, but failed to resolve the question of whether or not asymptomatic bacteriuria was merely a marker for low socioeconomic status, which is associated with low birthweight (<a href="./references#CD000490-bbs2-0073" title="RomeroR , OyarzunE , MazorM , SirtoriM , HobbinsJC . Meta‐analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstetrics and Gynecology1989;73:577‐82. ">Romero 1989</a>). The authors of a recent systematic review concluded there was no reliable evidence to support routine screening for asymptomatic bacteriuria, given the serious methodological shortcomings of the studies identified, and the low number of outcomes reported from the more recent, high‐quality study (<a href="./references#CD000490-bbs2-0028" title="AngelescuK , Nussbaumer‐StreitB , SiebenW , ScheibierF , GartlehnerG . Benefits and harms of screening for and treatment of asymptomatic bacteriuria in pregnancy: a systematic review. BMC Pregnancy Childbirth2016;16(1):336. ">Angelescu 2016</a>). The recent publication from the Canadian Task Force on Preventive Health Care gave screening for asymptomatic bacteriuria in pregnancy a weak recommendation, based on very low‐quality evidence, because of the small but uncertain benefit, variation in women's values and preferences, and the judgment that harms were likely minimal (<a href="./references#CD000490-bbs2-0064" title="MooreA , DoullM , GradR , GroulxS , PottieK , TonelliM , et al. Recommendations on screening for asymptomatic bacteriuria in pregnancy. CMAJ2018;190(27):E823‐30. ">Moore 2018</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD000490-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/urn:x-wiley:14651858:media:CD000490:CD000490-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_t/tCD000490-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD000490-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/full#CD000490-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000490-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/urn:x-wiley:14651858:media:CD000490:CD000490-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_t/tCD000490-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study" data-id="CD000490-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/full#CD000490-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000490-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/urn:x-wiley:14651858:media:CD000490:CD000490-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_t/tCD000490-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Antibiotic versus no treatment for asymptomatic bacteriuria, outcome: 1.1 Development of pyelonephritis" data-id="CD000490-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Antibiotic versus no treatment for asymptomatic bacteriuria, outcome: 1.1 Development of pyelonephritis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/full#CD000490-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000490-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/urn:x-wiley:14651858:media:CD000490:CD000490-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_t/tCD000490-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotics versus no treatment for asymptomatic bacteriuria, Outcome 1 Development of pyelonephritis." data-id="CD000490-fig-0004" src="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Antibiotics versus no treatment for asymptomatic bacteriuria, Outcome 1 Development of pyelonephritis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/references#CD000490-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000490-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/urn:x-wiley:14651858:media:CD000490:CD000490-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_t/tCD000490-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotics versus no treatment for asymptomatic bacteriuria, Outcome 2 Preterm birth &lt; 37 weeks." data-id="CD000490-fig-0005" src="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Antibiotics versus no treatment for asymptomatic bacteriuria, Outcome 2 Preterm birth &lt; 37 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/references#CD000490-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000490-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/urn:x-wiley:14651858:media:CD000490:CD000490-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_t/tCD000490-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotics versus no treatment for asymptomatic bacteriuria, Outcome 3 Birthweight &lt; 2500 g." data-id="CD000490-fig-0006" src="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Antibiotics versus no treatment for asymptomatic bacteriuria, Outcome 3 Birthweight &lt; 2500 g. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/references#CD000490-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000490-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/urn:x-wiley:14651858:media:CD000490:CD000490-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_t/tCD000490-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotics versus no treatment for asymptomatic bacteriuria, Outcome 4 Persistent bacteriuria." data-id="CD000490-fig-0007" src="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Antibiotics versus no treatment for asymptomatic bacteriuria, Outcome 4 Persistent bacteriuria. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/references#CD000490-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000490-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/urn:x-wiley:14651858:media:CD000490:CD000490-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_t/tCD000490-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotics versus no treatment for asymptomatic bacteriuria, Outcome 5 Serious adverse neonatal outcome." data-id="CD000490-fig-0008" src="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Antibiotics versus no treatment for asymptomatic bacteriuria, Outcome 5 Serious adverse neonatal outcome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/references#CD000490-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000490-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/urn:x-wiley:14651858:media:CD000490:CD000490-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_t/tCD000490-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotics versus no treatment for asymptomatic bacteriuria, Outcome 6 Birthweight." data-id="CD000490-fig-0009" src="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Antibiotics versus no treatment for asymptomatic bacteriuria, Outcome 6 Birthweight. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/references#CD000490-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000490-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/urn:x-wiley:14651858:media:CD000490:CD000490-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_t/tCD000490-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotics versus no treatment for asymptomatic bacteriuria, Outcome 7 Gestational age at delivery." data-id="CD000490-fig-0010" src="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Antibiotics versus no treatment for asymptomatic bacteriuria, Outcome 7 Gestational age at delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/references#CD000490-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/media/CDSR/CD000490/image_n/nCD000490-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD000490-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antibiotics compared to no treatment for asymptomatic bacteriuria in pregnancy</span></div> <tbody> <tr class="table-header separated"> <td align="left" class="table-header" colspan="7" rowspan="1" valign="top"> <p><b>Antibiotics compared to no treatment for asymptomatic bacteriuria in pregnancy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> pregnant women with asymptomatic bacteriuria </p> <p><b>Setting:</b> hospital‐based clinics in North America, UK and Ireland, Australia; hospital and community midwifery practices in the Netherlands </p> <p><b>Intervention:</b> antibiotics </p> <p><b>Comparison:</b> no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with antibiotics</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Development of pyelonephritis</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.24<br/> (0.13 to 0.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2017<br/> (12 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>199 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>48 per 1000<br/> (26 to 82) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Preterm birth &lt; 37 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.34<br/> (0.13 to 0.88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>327<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>174 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>59 per 1000<br/> (23 to 153) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Birthweight &lt; 2500 g</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.64<br/> (0.45 to 0.93) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1437<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>e,f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>136 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>87 per 1000<br/> (61 to 126) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded 1 level for serious limitations in study design: most of the trials contributing outcome data either had important design limitations related to lack of allocation concealment and lack of blinding, or there were insufficient details provided in the report to assess risk of bias. Many of the studies were performed in the 1960s and 1970s, prior to more rigorous study designs and reporting standards.<br/> <sup>b</sup>We downgraded 1 level for serious limitations in inconsistency: the rate of pyelonephritis in the control groups ranged from 2.2% to 36%; there was significant heterogeneity, which was not explained by the duration of treatment (I² = 60%).<br/> <sup>c</sup>We downgraded 1 level for serious limitations in study design: only one trial was judged at low risk of bias across all domains; for the other two, the risk of bias was either unclear because details were not provided, or judged high risk.<br/> <sup>d</sup>We downgraded 1 level for serious limitations in indirectness: the rate of preterm birth in the control group ranged from 4.4% to 37.5%. There have been substantial changes in obstetric practices over the four decades from the earliest to the latest study. In one study, only women with group B streptococcus bacteriuria were enrolled, and treatment was with penicillin.<br/> <sup>e</sup>We downgraded 1 level for serious limitations in study design: all of the trials contributing outcome data either had important design limitations related to lack of allocation concealment and lack of blinding, or there were insufficient details provided in the report to assess risk of bias. The studies contributing data to this outcome were performed in the 1960s and 1970s, prior to more rigorous study designs and reporting standards.<br/> <sup>f</sup>We downgraded 1 level for serious limitations in indirectness: 5 of the 6 studies included in this outcome continued antibiotic treatment for 6 weeks (1 study), or until term (4 studies). In one study, women received a single dose of antibiotics, and in no study did women receive what is now considered a standard course of antibiotics for 3 to 7 days. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antibiotics compared to no treatment for asymptomatic bacteriuria in pregnancy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/full#CD000490-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000490-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antibiotics versus no treatment for asymptomatic bacteriuria</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Development of pyelonephritis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.13, 0.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Single dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>173</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.21, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Short course (3 to 7 days)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>568</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.11, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Intermediate course (3 to 6 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>433</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.08, 0.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Continuous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>843</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.04, 0.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Preterm birth &lt; 37 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>327</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.13, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Single dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Short course (3 to 7 days)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.05, 2.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Intermediate course (3 to 6 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Continuous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>173</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.14, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Birthweight &lt; 2500 g <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1437</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.45, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Single dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>413</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.36, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Short course (3 to 7 days)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Intermediate course (3 to 6 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>278</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.55, 2.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Continuous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>746</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.33, 0.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Persistent bacteriuria <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>596</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.18, 0.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Serious adverse neonatal outcome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>549</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.23, 1.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Birthweight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>498</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>21.03 [‐83.65, 125.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Gestational age at delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.01, 1.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antibiotics versus no treatment for asymptomatic bacteriuria</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000490.pub4/references#CD000490-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD000490.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD000490-note-0013">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD000490-note-0008">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD000490-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD000490-note-0007">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD000490-note-0005">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD000490-note-0009">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD000490-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD000490-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD000490-note-0003">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD000490-note-0001">繁體中文</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD000490-note-0010">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000490\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000490\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000490\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000490\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000490\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000490\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000490\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000490\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000490\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000490\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000490\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000490\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000490\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000490\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000490\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000490\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000490\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000490\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=eLIOL3Be&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000490.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000490.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD000490.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD000490.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000490.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714859061"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000490.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714859065"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000490.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d78f74c2b937d',t:'MTc0MDcxNDg1OS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 